Parametrising kinetic models of biological networks by Borger, Simon
Parametrising kinetic models of biological networks
D I S S E R TAT I O N
zur Erlangung des akademischen Grades
Dr. rer. nat.
im Fach Biophysik/Theoretische Biophysik
eingereicht an der
Mathematisch-Naturwissenschaftlichen Fakultät I
Humboldt-Universität zu Berlin
von
Dipl.-Phys. Simon Borger
geb. am 30.03.1975 in Berlin
Präsident der Humboldt-Universität zu Berlin:
Prof. Dr. Christoph Markschies
Dekan der Mathematisch-Naturwissenschaftlichen Fakultät I:
Prof. Dr. Christian Limberg
Gutachter:
1. Prof. Dr. Dr. h.c. Edda Klipp
2. Prof. Dr. Hermann-Georg Holzhütter
3. Prof. Dr. Thomas Höfer
4. Prof. Dr. Matthias Reuss
eingereicht am: 28. Januar 2008
Tag der mündlichen Prüfung: 10. Dezember 2008
Abstract
Systems biology seeks to model biological networks dynamically. Two require-
ments need to be fulfilled for this to be possible. First, the interaction networks
need to be known. Second, the dynamics of the interactions have to be revealed.
Dynamics of interactions are described by rate laws using kinetics. These kinet-
ics describe the interaction mechanism. For each single interaction occurring in
a biological network parameters have to specified. They have to be measured by
experiments. For enzyme catalysed reactions, for example, the parameters are mea-
sured by enzyme assays tracking the consumption of substrate. For many enzymes
parameters and kinetic mechanism are not known. And existing data for parame-
ters generally are of poor quality. After introducing kinetic modelling of metabolic
networks we consider a published artificial genetic network that can either tend to
a steady state or exhibit sustained oscillations depending on a critical parameter.
This critical parameter is the Hill coefficient in the interaction from one gene with
the other. For different parameter settings we examine at what value of the Hill
coefficient a bifurcation occurs. At this point the network begins to oscillate. We
thus assess the distribution of the critical values, a property that cannot be calcu-
lated analytically. We then go on to consider useful data sources for parmetrisation
of kinetic models of metabolic networks and collect them in an electronical resource
to make them electronically accessible and usable. This requires choosing standard
references for the designation of components of biological networks. Finally we de-
scribe a workflow in which this data resource is used for automatic parametrisation
of kinetic models of metabolic networks.
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Zusammenfassung
Systembiologie strebt danach, biologische Netzwerke dynamisch zu modellieren.
Zwei Erfordernisse sind zu erfüllen, damit dies möglich wird. Erstens müssen die
Interaktionsnetzwerke bekannt sein. Zweitens muss die Dynamik einer jeden Inter-
aktion aufgedeckt werden. Die Dynamik von Interaktionen werden durch Ratenglei-
chungen beschrieben unter Verwendung von Kinetiken. Diese Kinetiken beschreiben
den Interaktionsmechanismus. Für jede einzelne Interaktion, die in einem Netwerk
auftritt, müssen Parameter bestimmt werden. Sie sind durch das Experiment zu
messen. Für enzymkatalysierte Reaktionen zum Beispiel werden Messungen durch-
geführt, in welchen der Verbrauch des Substrates aufgezeichnet wird. Für viele En-
zyme jedoch sind weder der Mechanismus geschweige denn die Parameter bekannt.
Und vorhandene Daten sind gewöhnlich von mangelhafter Qualität. Nach einer Ein-
führung in die kinetische Modellierung metabolischer Netzwerke betrachten wir ein
veröffentlichtes künstliches genetisches Netzwerk, das entweder einem stationären
Zustand zustrebt oder in Abhängigkeit eines kritschen Parameters in einen dauer-
haften Schwingungszustand übergeht. Dieser kritsche Parameter ist der Hillkoeffizi-
ent in der Wechselwirkung zwischen einem Gen und dem anderen. Für verschiedene
Parameterwahlen untersuchen wir, bei welchemWert des Hillkoeffizienten eine Bifur-
kation auftritt. Hier fängt das Netzwerk zu schwingen an. Auf diese Weise ermitteln
wir die Verteilung des kritschen Parameters, der nicht analytisch berechnet werden
kann. Wir fahren dann fort und untersuchen nützliche Datenquellen für die Para-
metrisierung von kinetischen Modellen metabolischer Netzwerke und sammeln sie
in einer elektronischen Ressource, um sie auf elektronischem Wege zugänglich und
nutzbar zu machen. Dies erfordert, Standardreferenzen zu wählen für die Benennung
der Komponenten biologischer Netzwerke. Schließlich beschreiben wir einen Arbeits-
ablauf, während desselben die Datenbank verwendet wird zur Parametrisierung von
kinetischen Modellen metabolischer Netzwerke.
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1 Systems biology
1.1 Life is more than the sum of its parts
The ultimate goal of biology is to understand life. The domain of life is the world of
organisms as opposed to the inorganic, dead matter. Living organisms are characterised
by growth, reproduction and adaptation to their environment. All species from the
unicellular to multicellular creatures, like mammals with intricate anatomies, live and
survive in an environment that at the same time is friend and foe, that feeds and men-
aces them while they go through their life cycle producing offspring. In the process of
reproduction the genetic material is passed on to the offspring to equip them with the
arsenal that enables them to survive and proliferate.
Underlying this passage through the life cycle is a wealth of processes. These processes
comprise uptake and digestion of nutrients, defense of stressors, the assembly of cellular
components, processing of and response to hormones. They are at the basis of growth
and reproduction and give rise to what is called the functions of an organism, i.e. all
those means and ways the organism shows up with at the physiological level to make its
species survive.
All these processes are achieved by thousands of proteins cooperating to form func-
tional modules. Among these are signalling pathways, metabolic pathways and the gene
expression apparatus. Proteins are important in the cell’s signal transduction appara-
tus for immune responses or cell fate decisions. They drive the cell cycle or facilitate
metabolism by speeding up biochemical reactions. The cell’s shape is supported by pro-
teins forming the cytoskeleton. Proteins are also involved in muscle contraction, cell
division and motility.
Molecular biology and biochemistry have revealed a lot about the basic processes of
life. Genes were discovered and the helical structure of the DNA was determined. How
genes are induced by activators or impeded by repressors has been described. Proteins
have been sequenced and exposed to X-rays to reveal their complex three dimensional
shape. That differences in morphogen are decisive in cell development has been under-
stood.
But life hides more puzzles than those uncovered by molecular biology. An example is
robustness which is the property of a system to maintain its function and pursue its pur-
pose despite external or internal perturbations. For instance the bacterium Escherichia
coli living in the intestines of humans shows this remarkable property. It directs its
movement towards a source of nutrient by sensing where the nutrient concentration is
highest in its surrounding. Amazingly, this sensory system performs reliably across a
wide range from small to large concentration differences. Robustness is a phenomenon
encountered in biology that cannot be explained on a molecular basis going through a
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series of events step-by-step.
Recent years have seen the advent of a new era in biology. This era is witnessing the
breakthrough of a new field called systems biology. Although lacking a solid definition
this name has generally been accepted and is widely used. Sometimes systems biology is
characterised as being the opposite to the reductionist approach, rather taking a holistic
standpoint and considering entire biological systems or subsystems than dissecting them
into molecules. Systems biology is an integrative discipline that builds on the revealed
molecular details and takes a step back to regard the system as a whole.
In 1961, W.B. Astbury writes that he perceived molecular biology, generally viewed
as an embodiment of reductionism, as “an approach from the viewpoint of the so-called
basic sciences with the leading idea of searching below the large-scale manifestations of
classical biology for the corresponding molecular plan.” [9] Molecular biology has studied
the components of the molecular plan of the cell in isolation. The belief of molecular
biologists was that an appropriate description of the large-scale properties of the cell
would arise from simply joining the properties of its components into a large picture.
That this view is a too reductionist is being affirmed by a growing number of biologists.
So systems biology then is concerned with those large-scale manifestations. It might
seem that biologists are walking around in circles, leaving those large-scale manifestations
of classical biology for the reductionist and more basic perspective of molecular biology
to finally return to the large-scale manifestations with systems biology.
In its so-called bottom-up approach, systems biology unites knowledge about com-
ponents of the large-scale manifestations and their interactions. “It is about putting
together rather than taking apart, integration rather than reduction. It starts with
what we have learned from the reductionist approach; and then goes further. It requires
that we develop ways of thinking about integration that are as rigorous as our reduction-
ist programmes, but different. This is a major change. It has implications beyond the
purely scientific. It means changing our philosophy, in the full sense of the term.” [111].
Once the components have been put together to form a system, how then does it
behave? Systems biology is setting out to explain the dynamical properties of these
systems based on the properties of their parts and how they act upon each other. The
dynamics are brought about by the interactions among the parts. In the focus systems
biology is not only the question of which components interact, but also to what extent
they interact and how the interactions change during the course of time.
The dynamic properties that emerge from the systems level description of the compo-
nents and their interactions are the novel point about systems biology. It is not possible
to understand the properties of systems and thereby their functions, without examining
how their parts are connected and drive each other. One does not know what a leg is
good for if one disregards the the rest of the body it is attached to. An ant from the
worker caste fulfills its function only as a cogwheel within the whole colony.
Examples of emergent system properties in the cell are memory or periodic rhythms.
Memory emerges as a property when a system being in either of two states cannot
effortlessly be prompted to move to the other. This phenomenon is called bistability.
The memory of the brain or the immune system and cell fate decision are explained based
on bistability [147, 17, 89]. In a model of the cell cycle the critical cell volume on which
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onset of DNA replication depends, emerges as a system property [11]. A model of the
cardiac muscle brings about the pacemaker rhythm of the heart [110]. Oscillations are
also seen in engineered genetic regulatory networks as consequence of negative feedback
like in a cycle with successive inhibitions [45].
By revealing basic functions of living organisms by studying systems as whole, biology
is walking in circles and coming back to the large-scale manifestations in the sense that
the perspective is a holistic one. But this approach is based on the reductionist view.
The systems studied in systems biology are made up of the parts that molecular biology
unearthed. And systems biology now is putting the puzzle together and discovering that
living systems are more than the sum of their parts.
1.2 Living networks
The objects of study of systems biology are biological networks. A network is per defi-
nition a collection of nodes and of connections between them. The nodes communicate
through the connections. The message communicated depends on the state of the inter-
acting nodes, on the type of interaction and possibly on external factors.
A key feature of networks is their dynamics. That is, the state of a network undergoes
temporal change because the nodes interact. Often, without external forces a network
will tend towards a constant state.
Everyday life examples of networks are landline or cellular telephone networks, com-
puter networks like the internet, social networks like bridge clubs, or traffic networks
like a railway system.
If we take a closer look at the rail network example, we could ask ourselves what the
railway operator has to consider in order to secure good service of the rail network. For
instance there should be no time delays and thus no hold up on the tracks.
In a rail network trains travel constantly between different destinations transporting
people and goods.
Good functioning requires not only a timetable such that trains are coordinated, but
also measures against unforeseen incidents like a train that has jumped out of the rails or
damages through weather. A rail network requires overall planning and enough flexibility
to be able to maintain a minimum of service in unforeseen cases.
In biology networks are ubiquitous. The brain is a network of neurons that exchange
signals through synaptic transmission. The food chains of animals and plants constitute
ecological or predator-prey networks. Any higher-level creature contains a hierarchy of
networks. The organs and the blood system constitute a network. Tissues consist of
many interacting cells. And finally, the cell itself is a complex network.
The cellular network is far from being fully apprehended. The cell is a network that
can only be understood in terms of its dynamics arising from the interactions. The
central dogma of molecular biology, stating that a gene is transcribed and translated
into a protein, brings the two main networks into play. A cell’s genes and its proteins
are the key players of a living cell. The genes contain the building plans of the proteins.
The building plans entail certain attributes of the proteins that make them acomplish
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certain purposes within the cell. They assist in turning sugar into energy or in fighting
and disarming malign intruders. Coordinating all those proteins lets the cell fulfil its
functions like growth, immune response or cell devision in a coordinated fashion to finally
reproduce.
Biological ones are built of nodes and interactions between them. The set of all genes,
the genome, form a network. A gene is expressed, through transcription and translation,
to bring forth the coded protein. Either directly, as a transcription factor, or indirectly,
in a signalling pathway, the protein then acts back on the genome, possibly the original
gene or others. The genes form a network and interact through the proteins they encode.
From a different perspective, the set of proteins make up an interaction network. One
can distinguish between different types of protein networks depending on the nature of
the interaction. They could be called the cellular computer, the cellular factory and
cellular workhorses, respectively.
The networks that make up the cell’s computer are the so-called signalling pathways.
The cell receives signals from its environment and processes them by signalling cascades.
Proteins activate and inactivate each other, switch each other on and off, by exchanging
functional groups like phosphate. At the end of the cascade a protein is switched on and
affects the transcription of target genes. By thus processing signals the cell reacts to
changes in the environment. Hormones for instance invoke cellular differentiation during
embryo development to grow different tissues and parts of the anatomy.
The cellular factory consists of another group of proteins, the enzymes. Nutrients
like sugar are digested for energy production that is needed in other cellular processes
like the synthesis of the proteins. The sugar gets broken down into smaller molecules
through a series of biochemical reactions, the so-called metabolic pathways. Enzymes
drive metabolism by speeding up the biochemcial reactions. Enzymes interact indirectly
by passing down metabolites from one to the other along the metabolic pathways.
The third type of protein interaction network, the cellular workhorses, are single large
molecules composed of many proteins bound in a complex. The proteins fulfil their
purpose only in conjunction with the others in the complex. The binding of the proteins is
stable over time as compared to those protein-protein interactions in signalling pathways
where proteins bind shortly to exchange groups. An example of such a molecule requiring
many proteins bound in a complex is the ribosome. It consists of RNA and several tens
of proteins. The ribosome is responsible for protein biosynthesis in gene expression by
translating the genetic code into an amino acid sequence.
The interactions among the components of the cell that make up the cellular networks
and govern its dynamics are intrinsically non-linear. This means that the rates of pro-
cesses in the cell do not grow or shrink proportionally to what drives them, i.e. the abun-
dances of the biomolecules. A well known non-linearity is found in the rate of enzyme-
catalysed reactions, the rates of which are limited by the total enzyme amount, leading
to saturation and a maximal reaction rate. Other non-linearities in many metabolic
pathways and gene regulatory networks arise from feedback. In negative feedback, for
instance, the response decreases a signal after an increase of the signal. An example is
the inhibition of the glucose transport into the cell by Glucose 6-phosphate, a metabolite
in glycolysis pathway, after uptake of glucose.
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And indeed, the non-linearities of the interactions are at the core of control and
regulation of cellular processes. No cell could survive an ever increasing concentration
of a metabolite. So there have to be means and ways to keep the cellular state within
a physiological range despite of environmental influences. Some properties of organism
even stay constant in changing environments like the body temperature of mammals.
The non-linear interactions give rise to the cell’s functions. This is what is meant when
one speaks of properties of networks emerging from the interactions. These emerging
properties are often said to be counter-intuitive [17, 138] which is due to the non-linear
nature.
For instance, protein networks involved in signalling or the control of metabolism
exhibit ultrasensitivity and constitute switches swapping between two states. Due to
the non-linearities the switch can be very sharp with an on-off-profile requiring a signal
above a threshold to get the response [65, 66]. Memory arises in cell development from
positive feed-back, a non-linear interaction causing two stable states for a certain range
of signal strength and discontinuous switching at the borders of this range [138]. The
value of the response within the signal range of bistability depends on the history of the
system. The adaptation of organisms to the daily rhythm, so-called circadian rhythms,
also emerge from non-linear feedback properties of the network interactions [64].
1.3 Models of biological networks
Setting up models of biological interaction networks like a metabolic or a signalling
pathway is a three-fold process. As networks are described by nodes and interactions,
first the nodes and the connections between them have to be identified.
Second, the nature of the interaction between two nodes has to be assessed. This is
especially true for enzymes when several metabolites and effectors can bind to it. For
instance do we need to know for an enzyme catalysing a reaction with two substrates
whether the temporal order of binding to the enzyme is relevant. There might also be
effectors inhibiting or activating the binding of a metabolite.
Third, the kinetic expressions of the interactions need to be assigned parameters.
The mathematical description of the non-linear interactions in the cellular networks
phenomenologically sums up detailed processes. Protein-protein binding or substrate-
enzyme binding are intricate series of events involving conformational changes of the
proteins. Mass action or kinetics derived therefrom are coarse-grained views of these
events encompassing different time scales. Different kinetics for protein binding have
been developed from mass action by separating fast from slower processes, among them
the famous Michaelis-Menten and the Hill kinetics. As these kinetics are phenomeno-
logical descriptions of detailed processes the parameters for the kinetics describing them
need to be measured for every single possible interaction.
For what concerns the first step, the identification of the cellular protein networks,
molecular biology, biochemistry and genetics have set out a picture of the hierarchy of
networks and its components. As the catalogue of components is so tremendous this
job is still not finished. In the nineties the rise of genomics led to the decoding of
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the first genomes containing millions of base pairs and culminated in the completion of
deciphering the euchromatic human genome in 2004 [34]. In the following years then,
between 1995 and 2004, the number of deciphered genomes grew exponentially [121]. As
of October 2007 the number of complete genomes, publicly available at NCBI (National
Center of Biotechnolgy Information), is 24 for eukaryotes [51] and 594 for archaea and
bacteria [52]. The sequencing of complete genomes has accelerated the discovery of new
genes by 50–100 times [118] compared to classical genetics.
To date the function of many genes and their protein products remains unknown. In
1996, the year the genome of the first eukaryote, of the yeast Saccharomyces cerevisiae,
was completely deciphered, nearly half of the genes newly discovered through genome
sequencing was completely unknown [118].
The knowledge of the mere genomic sequences is of value in evolutionary and phylo-
genetic studies as their similarity within and across species can be studied. Apart from
that, the genetic sequence only determines the amino acid sequence of the encoded pro-
tein and tells us nothing about the process and function the protein might play a role
in (despite efforts to explain protein properties from their sequences). So for systems
biology, sequenced genomes alone remain meaningless series of the letters A, C, T and
G like the words of a foreign language the words of which we cannot convert into sound
or meaning.
To get a feeling of the effort that awaits biologists when it comes to make meaning of
the human proteome take a look at the size of the genome. It has a length of approx-
imately 3000 Mbp. It is 250 times larger in terms of nucleotides than the genome of
Saccharomyces cerevisiae. There had been wild speculations about the number of human
genes contained in those 3000 Mbp. By the year 2004 it came as a big surprise that the
human genome contains only 20000–25000 genes [34], that is only approximately 4 times
as many as for Saccharomyces cerevisiae. But this number of genes is faced by a much
larger number of proteins due to a combinatorically increased number of ways of reading
the single gene through alternative splicing and post-translational modification [82, 20].
Current estimates say that one gene can yield up to 60 different proteins leading to a
number of different human protein species that exceeds one million [82]. At the UniProt
database [6] in the current version 17316 human proteins have reviewed annotations [37]
which amounts to on the order 1% of the protein total.
What about the functional annotation of the genome of a smaller and well studied
organism? The yeast Saccharomyces cerevisiae is a so-called model organism being the
first eukaryote to have been sequenced with a fairly small genome of a length of 12.1
Mbp (mega base pairs, i.e. nucleotides) encoding approximately 6000 genes [53]. It is
unicellular and because it shares homologs, i.e. evolutionarily connected, genes with
human, knowledge gained about Saccharomyces cerevisiae has value for the study of
human genes, in particular diseas involved genes. As of April 2007 the SGD Project [28,
123] and the Gene Ontology Consortium [8, 32] report that out of 5790 ORFs (open
reading frames) of the yeast Saccharomyces cerevisiae 3698, 4400 and 4946 are annotated
to a term of the controlled vocabularies describing the molecular function, the cellular
component, or the biological process, respectively [33]. Yet, many annotations are based
on large-scale analyses, and caution seems advisable as to their correctness [122]. And
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the number of uncharacterised ORFs has recently reduced much more slowly than before.
This lack of knowledge about protein function entails considerable uncertainty in large-
scale networks of systems biology [56].
For what concerns the type of interactions in the cellular networks, they can only
be known by investigating each actual interaction on its own. Enzyme assays examine
the kinetics of the reaction an enzyme catalyses measuring either the consumption of
substrate or the yield of product over time. Techniques include initial rate measurements
or progress curve experiments. When enzyme assays are conducted and documented
correctly both the kinetic mechanism and its parameters it are determined [47]. In the
literature it happens however that enzyme kinetic parameters are given without any
information on the mechanism. The STRENDA Commission endeavours to establish
standards for the reporting of enzyme assay results for them to be of optimal use for
scientists.
Other interactions like protein complex forming or activation and deactivation of pro-
teins by kinases and phosphatases are often modelled with mass action kinetics.
A given model of a cellular network with fully parametrised interactions should be
compared to experimental results. This means that an experiment should measure the
concentrations of all involved components, preferably across a time interval of interest.
The only one among the concentrations of the constituents of the cellular network we
know is that of the genes, there being one genome per cell.
Other components of cellular networks like mRNA, proteins and metabolites need
to be measured to get an impression of their abundance under certain environmental
conditions. As measurements of abundances at certain time points are snapshots of
the momentary state of a cell, they do not as such reveal any dynamic information.
Snapshots of the protein total have medical value by discovering so-called biomarkers
that indicate a particular disease as well as possibly a susceptibility to a treatment. In
Alzheimer’s disease plaques of proteins build up in the brain. The protein, amyloid beta
protein, can be examined for increased levels with proteomic techniques.
To gain dynamical information, several snapshots taken at intervals, so-called time
series, are needed. They can be compared to the outcome of a model simulation. If a
model is not fully parametrised one can also use a time series of snapshots for parameter
estimation. This is because the path from one snapshot to the other is governed by the
system’s interactions and thus by the parameters used to describe them.
Current technologies for measuring components of the cellular network include mi-
croarrays to measure genome-wide relative mRNA concentrations. Quantitative pro-
teomics based on mass spectrometry yield relative abundances of proteins. Measure-
ments of the entire metabolite content of cells, the so-called metabolome, have to date
not yet been accomplished. The major hurdle for metabolomics is to set up an inventory
of metabolic compounds. A first attempt to this end has been undertaken by the Human
Metabolome Project that has collected information on about 2500 metabolites into the
Human Metabolome Database [145].
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1.4 Standards for life sciences
“By the late 1950’s it had become evident that the nomenclature of en-
zymology, in the absence of any guiding authority, in a period when the
number of known enzymes was increasing rapidly, was getting out of hand.
The naming of enzymes by individual workers had proved far from satisfac-
tory in practice. In many cases the same enzymes became known by several
different names, while conversely the same name was sometimes given to dif-
ferent enzymes. Many of the names conveyed little or no idea of the nature of
the reactions catalysed, and similar names were sometimes given to enzymes
of quite different types. To meet this situation, various attempts to bring
order into the general nomenclature of enzymes, or into that of particular
groups of enzymes, were made by individuals or small groups of specialists,
but none of the resulting nomenclatures met with general approval.
In view of this state of affairs, the General Assembly of the Interna-
tional Union of Biochemistry (IUB) decided, during the third International
Congress of Biochemistry in Brussels in August, 1955, to set up an Interna-
tional Commission on Enzymes.”
This quotation from the Enzyme Nomenclature 1992 [142] describes a situation where
standards have not yet been set up and what confusion ensues. Science as an organised
body of knowledge requires conventions of knowledge representation so that this knowl-
edge can be shared and exchanged. This is fundamental to science in general and to
bioinformatics and systems biology as young emerging fields of research in particular.
Standards for a field of knowledge provide a common language that enables scientists to
communicate unambiguously about pieces of knowledge of that field.
The increasing amounts of data being generated in biology by high-throughput tech-
niques offer the chance to gain a view of entire biological systems. These data are
available to bioinformaticians and biostatisticians who set up databases and develop
comparative tools that categorise and structure data and find connections between data
sets. These data serve modellers in systems biology who integrate them into their models
of biological networks seeking to simulate entire biological systems.
Today, with increasing amounts of omics data, and with the internet allowing for data
exchange at high rates, the need for standards is even more urgent. The challenge is to
make sensible use of the data that are produced in volumes requiring electronical means
for processing and integration. Data from high-throughput experiments are stored in
databases to offer widespread access to them.
Not only standardised ways of talking about a domain of knowledge are needed as
ever more knowledge is stored electronically. Electronical storage requires the standards
to be translated into electronical formats in order to enable electronical communication
between tools generating, storing, analysing and utilising the data. A prominent and
widely used electronical format is XML. SBML (Systems Biology Markup Language), a
format for encoding dynamical models of biological interaction networks, is a derivative
of XML.
8
1.4 Standards for life sciences
Electronical exchange formats themselves are based on object models and ontologies
for a specific field of knowledge. These define a vocabulary to represent shared knowledge
about objects of a field of knowledge and their relationships; the so-called universe
of discourse. The definition provides a nomenclature and system of identification of
the objects. ChEBI (Chemical Entities of Biological Interest) [42] is an example of
an ontology defining the universe of the so-called small biochemical compounds. The
ongoing development of numerous ontologies and the corresponding electronical formats
as well as of new standardisation projects have resulted from the need to share knowledge.
These ontologies are available from the Open Biomedical Ontologies (OBO) website [35].
The construction of those databases, on the other hand, requires formats of represen-
tation of the stored information. These formats correspond to specific object models
that conceptualize a domain of research and determine the structure of the stored in-
formation. In the area of microarray gene expression data, for instance, the MIAME
guidelines [24] for reporting of experimental results have facilitated [26] a flow of data
from laboratories into public repositories such as ArrayExpress [25, 10] and Gene Ex-
pression Omnibus (GEO) [12, 50].
Information formats of databases contain an inherent data model. For experimental
data the formats specify the necessary information for meaningful interpretation of the
data. This is necessary if experiments are to be reproducible.
Scientists have to sit down and agree on standards. In the era of systems biology
newly developed standards are emerging for purely biological domains, for information on
experimental data and for models of biological networks. One of the first initiatives along
this lines for experimental data was MIAME which standardised the way of reporting
about Microarray experiments [24]. There are several follow-up standardisation projects,
e.g. MIAPE [133] or STRENDA [7]. A prominent example of a standardisation of
biological knowledge is the GO (Gene Ontology) [8, 32] which provides a controlled
vocabulary to assign attributes to genes and gene products in any organism. GO has
been widely accepted and is used, for instance, by the SGD project [123].
For dynamical models of biological networks standards have been developed and
summed up in the MIRIAM recommendations [100]. MIRIAM [43] is a set of guide-
lines for annotation of dynamical models with emphasis on the identification of model
components such as metabolites or enzymes. Model standardisation is necessary if mod-
els are to be comparable, expandable and exchangeable [94]. To this end the Systems
Biology Markup Language (SBML) has been developed which is format for the publi-
cation of models [74]. A standard for model annotation called MIRIAM has been set
up [100].
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2 Metabolic Networks
2.1 Metabolism
Metabolism is the set of all biochemical reactions taking place in a cell. The reactions
group into pathways by sharing metabolites. The pathways fulfil functions of the living
cell allowing it to grow and reproduce by conveying biomaterial to its destination. Gen-
erally they are divided into two classes, catabolism and anabolism. Catabolic pathways
take up molecules from the environment, so-called fuel molecules like carbohydrates,
fatty acids or proteins and break them down into their parts thereby releasing energy in
the form of ATP. An example of a catabolic pathway is glycolysis in which the cell gains
two molecules of ATP and NADH from one molecule of glucose by being metabolised
into two pyruvate molecules. The anabolic pathways, on the other hand, use the com-
ponents of the macromolecules to construct new molecules that the cell needs, thereby
consuming energy. Amino acid synthesis or pyrmidine synthesis are examples of an-
abolic pathways. The citric acid cycle plays a role in both catabolism and anabolism
by burning fuel molecules in aerobic respiration and delivering precursor molecules for
amino or fatty acids.
The biochemicals participating in metabolism can be devided into two groups. Those
molecules that are consumed and produced in reactions in the course of the metabolic
pathways are the metabolites. They constitute the metabolic flux to yield an end prod-
uct. The other biochemicals take part in the reactions but leave them unchanged or
get produced in one and consumed in another reaction. Enzymes, for instance, catalyse
the reactions and drive the flux through pathways. Coenzymes are carriers of functional
groups required or generated by a reaction. Coenzymes take them up or loose them in
the course of a reaction. ATP is a ubiquitous coenzyme being produced in catabolic
pathways from ADP and a phosphate group. In anabolic pathways a phosphate group
from ATP is consumed leaving ADP.
2.2 Kinetic models of metabolic networks
The cell is an open system. It is embedded in an environment in which constantly
changes occur that affect the cell. From this environment it extracts its nutrients. But
it is also exposed to stress coming from the environment or receives hormones from other
cells. The cell has to respond to these external influences and at the same time maintain
its viability. It has to ensure essential functions like cell growth and cell cycle in an
environment that constantly changes.
The complex apparatus that the cell uses to communicate with the environment is
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the network of signalling pathways. The signalling pathways process and respond to the
information the cell receives from its environment. The receptors form the interface.
The stimuli are sensed by the receptors and induce the signalling pathways. At the
end of a cascade of protein-protein interactions activated transcription factors act upon
target genes leading to altered transcription with changed levels of abundances of the
corresponding proteins. Among those proteins there are possibly further transcription
factors, possibly also enzymes or other proteins. The enzymes will alter the flux through
metabolic pathways they control to yield a change in the abundance of the products of
the pathway needed by the cell for homeostasis, growth and reproduction.
Metabolism is a dynamical process. Mass constantly flows along the metabolic path-
ways. In a constant environment metabolic fluxes will not change over time. For instance
in one supplying enough nutrient, a population of yeast cells will ideally grow exponen-
tially for some time as each single cell grows at a constant rate. Upon changes in the
environment, the cell responds by adapting the fluxes like those producing material for
growth during a transient phase and will end up in another steady state if no further
environmental changes occur.
Modelling the metabolism of a cell will have to account for its dynamical nature. The
fundamental quantities of metabolic models are the concentrations of the biochemical
species, basically enzymes and metabolites, and the reaction rates that measure the con-
version of biochemicals. In the modelling of chemical reaction systems two approaches
have been developed. Both approaches assume that molecules diffuse freely in the re-
garded compartment and that the number of reactions occurring in a time increment δt
is proportional to the number of collisions of the reactants in δt that exceed a certain
kinetic energy threshold beyond which the reaction takes place.
The two approaches could be called the microscopic and the macroscopic one. Let us
take a look at a simple reaction
A+B k−→ X (2.1)
with reaction constant k.
Stochastic kinetics
The microscopic, commonly called the stochastic approach counts the molecule numbers
of each species and takes into account each single reaction event. Collisions per time
interval δt are interpreted in terms of probabilities, i.e. the probability of a reaction
occurring is proportional to the number of appropriate collisions:
probability of reaction in δt ∝ collisions in δt .
The number of collisions itself is proportional to the number of possible reaction partners,
A · B in the case of reaction (2.1) where A and B stand for the molecule numbers of
the respective species. For the above reaction (2.1), the probability of a reaction event
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occurring within a time increment δt is then [59]:
probability of reaction in δt = k ·A ·B · δt+ o(δt2) (2.2)
with k the reaction constant. If a reaction event takes place the number of molecules
will change to A− 1 and B − 1.
Deterministic kinetics
The macroscopic, commonly called the deterministic approach does not account for every
single reaction event and usually measures amounts in concentrations. It interprets the
collision frequencies in terms of rates, i.e.
rate of reaction at t ∝ collisions at t .
It is viewed as a limiting case of the stochastic approach for infinite molecule numbers.
Fluctuations and correlations between species are disregarded. Each reaction is assigned
a rate. For the above reaction (2.1), the rate, similarly to the stochastic approach, then
is
rate of reaction = k · V ·A ·B (2.3)
where V is the volume of the system and k the reaction constant. It is included because
in the deterministic approach the variables A and B stand for the concentrations of the
respective species. If we denote the reaction rate by v, then the concentrations of species
A and B will change by dA = dB = −v dt in a time increment dt.
2.2.1 Deterministic modelling
In deterministic modelling, the temporal evolution of metabolic networks is described
by a differential equation system for the state S which is the vector of concentrations of
the biochemical species. The concentration of each species changes with the reactions it
participates in. This change is a linear combination, a weighted sum over the respective
reaction rates where the weights are the stoichiometric coefficients of the species in those
reactions. Thus, the temporal evolution of the state S can be expressed as the product
of a matrix and a vector:
dS
dt
= N · v(S, p) . (2.4)
N is the stoichiometric matrix and encodes the structure of the metabolic network. The
rows denote the species and the columns the reactions. The entries in a row shows the
reaction a species is involved in either as a reactant or as a product. The entries in a
column, on the other hand, say which species are consumed or produced in a reaction
and how many molecules of each are involved. The reaction rates are denoted by v and
depend on the concentrations of the species S and parameters p, e.g. reaction constants
for the case of mass action and intial concentrations of the biochemical species.
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2.3 Time scales and dimensional reduction
Metabolism involves a vast span of time scales across several orders of magnitude (s.
Tbl. 2.1). The fastest processes include binding of substrates to enzymes that happen
on the micro- to millisecond time scale [14, 44, 47]. Once the substrate is bound to the
enzyme it is turned over into product within a fraction of to tens of milliseconds [14, 44,
47]. Metabolic pathways reach their steady state on the scale of tens of seconds up to
an hour [93, 136]. Regulation through enzyme synthesis in response to environmental
changes takes tens of minutes up to several hours [39, 137, 29]. Protein degradation
acts on a wide range of time scales encompassing long-lived proteins that last up to 106s
down to short-lived ones with a life-time of seconds.
The main players in metabolism, the enzymes and metabolites, undergo temporal
change on different time scales. Models of metabolic pathways focus on the dynamics
of the concentrations of metabolites and the distribution of metabolic fluxes in steady
state. The enzymes, on the other hand, are often taken not to or to change much more
slowly in their concentrations.
By a change in concentration, enzymes exert control on the fluxes through them. The
biotechnological industry, for instance, is interested in those enzymes that exert the
major control on a pathway in order to engineer strains with improved antibiotics yields
while at the same time avoiding by-product formation.
The main processes in metabolism are enzyme-substrate binding, substrate turnover
and change of enzyme conentration levels. The processes can be categorised into three
groups according to the time scales on which they happen.
1. The fast processes compared to metabolite turnover rates are substrate-enzyme
binding processes.
2. Metabolite turnover is the process of interest in models of metabolic networks.
Thus, its time scale is in the focus of any model of a metabolitc network.
For instance in the yeast Saccharomyces cerevisiae, with a cell volume of approx-
imately 70µm3 = 0.07pL [107], a substrate concentration of 1mM [2] would cor-
respond to 4 · 107 molecules in the cell. With an enzyme taking 10−3s to turn
over a substrate molecule and assuming an enzyme concentration of 1µM (4 · 104
enzymes per cell), it would take approximately 10s to convert the amount of sub-
strate into product, thereby neglecting reversibility of the process and incomplete
enzyme saturation.
3. Slow processes relative to metabolite turnover are gene expression and enzyme syn-
thesis. Protein degradation is disregarded in models of metabolism. For metabolism
in the yeast Saccharomyces cerevisiae, for instance, enzymes belong to the stable
proteins [13].
Different time scales in a modelled system entail mathematical simplicifications. It is
common to introduce a scaling parameter  with 0 <  1 [46, 30] to separate the time
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Time scales in metabolism
process time scale (s) reference
substrate-enzyme binding < 10−4 [14, 44, 47]
enzyme turnover 10−4–10−2 [14, 44, 47]
pathway transition to steady state 10 – 103 [93, 136]
gene expression 103–105 [39, 137, 29]
protein degradation 1–106 [139, 13]
Table 2.1: Processes in metabolism occur on a wide range of time scales.
scales. If the time scale of interest is denoted by t then the time scale of fast processes
becomes
tf =
t

(2.5)
and the time scale of slow processes
ts =  · t . (2.6)
Accordingly, we separate the dynamical system variables into fast variables xf , the
variables of interest x, and the slow variables xs. If on their respective time scales the
variables change according to
dxf
dtf
= gf (xf , x, xs, p)
dx
dt
= g(xf , x, xs, p)
dxs
dts
= gs(xf , x, xs, p)
then, on the time scale of interest t, the equations become
dxf
dt
= 1

· gf (xf , x, xs, p) (2.7)
dx
dt
= g(xf , x, xs, p) (2.8)
dxs
dt
=  · gs(xf , x, xs, p) (2.9)
(2.10)
As 0 <  1, we can immediately see that the slow variables xs hardly change, that is
dxs/dt ≈ 0, or
xs(t) ≈ x0s = const . (2.11)
On the other hand, the fast variables change very rapidly as 1/ will be very big and
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change until gf (xf , x, xs)  or
gf (xf , x, xs) ≈ 0 . (2.12)
This last condition, Eq.(2.12), imposes algebraic constraints on the solution to the dif-
ferential equation Eq.(2.8) and therefore on the dynamics of the variable of interest
x.
Michaelis-Menten model
In a famous example of separation of time scales the Michaelis-Menten kinetics were
derived for an irreversible enzyme-catalysed reaction involving one substrate and one
product:
S + E
k+1
⇀↽
k−1
ES
k2
→ P (2.13)
When this system is modelled according to Eq.(2.4) with reaction velocities described
by mass action kinetics, it comprises the four dynamic components S, E, ES, P , with
the three reaction rates k+1, k−1 and k2 and four initial values of the components as
parameters. The parameters k+1 and k−1 describe the rate of enzyme-substrate asso-
ciation and dissociation, respectively. The parameter k2 is called the turnover rate of
the enzyme. The four dynamical variables reduce to two because of the conservation
relations ET = E + ES = const and S + P = const.
Basis for the time scale separation in this system is the assumption the reversible
binding of the substrate to the enzyme occurs at a much faster rate, described by the
rate constants k+1 and k−1, than the turnover of the bound substrate and subsequent
release of product, described by the rate constant k2. Thus, in modelling this conversion
of substrate S to product P , the following simplification is made. Because the reversible
process
S + E
k+1
⇀↽
k−1
ES (2.14)
is much faster than the irreversible process
ES
k2
→ E + P , (2.15)
it is assumed that reaction (2.14) reaches a steady state before reaction (2.15) has had
a noteworthy effect on the system dynamics. This is called the quasi-steady state as-
sumption.
Schematically, after time scale separation the reaction can be represented in the sim-
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Example of reduction of model dimension
kinetics species conserved quantities parameters dimension
MA S, E, ES, P S + P k+1, k−1, k2 2
ET = E + ES
MM S, P S + P ET , k2, Km 1
Table 2.2: Processes in cellular biology span a vast range of time scales. When systems are
modelled that encompass very different time scales, simplifications in mathematical
description can be made through time scale separations. These reduce the size of
the phase space and the computational cost of simulation. In a classical example,
time scale separation was used in the description of the irreversible enzyme catalysed
reaction E + S ⇀↽ ES −→ P that reduces the model dimension from 2 to 1. This
lead to the famous Michaelis-Menten kinetics. (Abbreviations are MA: mass action,
MM: Michaelis–Menten.)
pler form
S
(ET ,Km,k2)−→ P . (2.16)
For the mathematical formula of the reaction kinetics see Eqs.(2.18), for its derivation
App.6.
The model corresponding to scheme (2.16) contains two dynamical variables S and P ,
constrained by the conservation S + P = const, and following parameters: two kinetic
constants KM and k2, the total enzyme concentration ET and two initial values for S
and P . The new parameter KM is called the Michaelis-Menten constant. The ratio
of the Michaelis-Menten constant Km and the substrate concentration S determine the
enzyme saturation (s. Eq.(2.20) and explanation thereafter).
In this description of a biochemical reaction in a metabolic pathway, the enzyme is
not a modelled species anymore. Rather its total concentration has become a parameter
of the reaction kinetics. Time scale separation reduces the dimensionality of a modelled
system (s. Tbl. 2.2) and thus saves computational costs.
For a derivation of the kinetics of this irreversible enzyme-catalysed reaction through
time scale separation see appendix 6.
2.4 Kinetics
Metabolic networks can be considered from two viewpoints. On the one hand, they
can be regarded as consisting of enzymes that interact by converting and passing on
metabolites from one to the next. On the other hand, the metabolites can be taken as
the nodes of the metabolic network that interact through biochemical reactions catalysed
by enzymes.
Deterministic modelling described by Eq.(2.4) in general is a combination of these
views. The nodes can be any biochemical molecule. The interaction can be transport,
binding, conversion or activation processes, subsumed under the notion of reaction. The
momentary concentrations of the biochemical molecules, encoded by the state S, change
through the reactions. The changes brought about by the reactions are expressed by
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the reaction velocities v(S, p). They depend on the state S itself and on the type of
interaction encoded in the functional form of v and its parameters p.
In a crude picture of catalysis, the metabolites bind to the enzymes which leads to a
conformational change of the enzyme facilitating the actual biochemical reaction. Each
enzyme mechanism is a special case of this description of catalysis, often involving further
details. Reversibility can come into play. Metabolites of the same species can cooperate.
Effectors can influence the binding properties of an enzyme, can strengthen, weaken or
even prevent binding.
Once the biomolecules bound to the enzyme are close enough for a reaction to happen,
series of successive events occur on different time scales and submolecular levels. The
modelling of biochemical reaction networks focusses on changes of the concentrations of
biochemical species and not on the details of how the reactions actually occur. It is thus
of importance to know the involved reactants, any details on submolecular levels are
disregarded and lumped into single rates. In fact, assigning a kinetic rate to a process
is a phenomenological black box description of the process.
The simplest form of kinetics in deterministic modelling of metabolic networks is mass
action kinetics. Mass action assigns a rate to each interaction between molecules that is
dependent on the concentrations of the reactants and the stoichiometry of the process.
Equilibria of reversible processes are characterised by the ratio of the rates in the two
directions. For instance, a reversible process between two states A and B going at rates
k+A and k−B,
A
k+
⇀↽
k−
B ,
has an equilibrium characterised by Beq/Aeq = k+/k−. This is called the law of mass
action [41].
In principle, any chemical reaction system can be modelled with mass action kinet-
ics. As cellular processes involve many different time scales (s. Sec. 2.3), modelling
metabolism has to account for the processes happening on these time scales. But mod-
elling all processes involved, from slow to fast, with mass action kinetics becomes cum-
bersome and computationally costly. Describing the dynamic evolution of every single
chemical species of the reaction system, including the intermediate binding complexes
of metabolites and enzymes, blows up the dimension of the differential equation system.
And the numerical effort increases not only with the dimension of the model, but also
by integrating across different time scales.
To dodge these difficulties in the modelling of metabolic networks, fast binding of
substrates and effectors compared to the conversion of substrate into product is as-
sumed. Furthermore, effects on enzyme concentrations due to gene expression are often
disregarded on the time scale of the catalysed biochemical reactions [30].
The simplest case of an enzyme-catalysed reaction is an irreversible reaction turning
a single substrate molecule A into a product molecule B:
S −→ P . (2.17)
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After separation of time scales (s. Secs. 2.3 and 6), the kinetics of this reaction are
described by the Michaelis-Menten equation:
dP
dt
= k2 ET
S
Km + S
(2.18)
= vmax
S
Km + S
(2.19)
= vmax
S˜
1 + S˜
, (2.20)
with vmax the maximal velocity of the reaction for a given total enzyme concentration,
Km the Michaelis-Menten constant and S˜ = S/Km.
The last version of Michaelis-Menten kinetics, Eq.(2.20), rescales the substrate con-
centration S in terms of the Michaelis-Menten constant. It emphasises that it is the
ratio S˜ = S/Km which determines the saturation of the enzyme
ES
ET
= S/Km1 + S/Km
.
Irreversibility of processes does not generally hold, but can be used as an approx-
imation as long as the substrate concentrations exceed those of the products by far.
Actually, more complex mechanisms are mostly at work accounting for more than one
molecule binding to an enzyme. The above reaction (2.17) in the reversible case,
S ⇀↽ P ,
can be modelled by the following phenomenological kinetics [92]
v = v
+
max (S/KmS)− v−max (P/KmP )
1 + S/KmS + P/KmP
. (2.21)
The large majority of enzymes actually catalyses reactions with two substrates [47].
When more than one substrate come into play several questions arise. The enzyme can
require a certain order of substrate binding. The enzyme Aspartate transcarbamylase
for instance, catalysing the reaction
carbamoyl phosphate + aspartate⇀↽ carbamoyl aspartate + phosphate ,
has a compulsory-order kinetic mechanism with Carbamoyl phosphate binding first [47].
Other enzymes require the second substrate to bind only after the first has been re-
leased where the enzyme is left with a chemical entity that the second substrate subse-
quently takes up. This is called the double-displacement mechanism. One speaks of a
random-order mechanism if any temporal order of the binding of substrates is possible
for catalysis.
These kinetics can become intricate when real metabolic pathways. Teusink et al. [136]
model the glycolytic pathway. One reaction of the pathway catalysed by the enzyme
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Fructose-bisphosphate aldolase (EC 4.1.2.13) is
F1,6BP⇀↽ GADP + DHAP (2.22)
where F1,6BP denotes D-Fructose 1,6-bisphosphate, DHAP stands for Dihydroxyacetone
phosphate and GADP means D-Glyceraldehyde 3-phosphate. The catalysed reaction is
assumed to follow an ordered uni-bi mechanism where the substrate F1,6BP splits into
the products DHAP and GADP with GADP being released first. If we abbreviate the
reaction (2.22) by S ⇀↽ P + Q, where the substrate is denoted by S and the products
DHAP by Q and GADP by P , respectively, the detailed reaction scheme reads
E⇀↽ ES⇀↽ EPQ⇀↽ EQ⇀↽ E
with kinetics [136, 101]
v = ET
k+cat
S
KS
(1− ΓKeq )
1 + SKS +
P
KP
+ QKQ +
SP
KSKiP
+ PQKPKQ
. (2.23)
The dissociation constants for the respective metabolites are KS , KP , KQ and KiP is
called the substrate inhibition constant of substrate P .
There are more aspects to enzyme kinetics. Modifiers can inhibit or activate an
enzyme. If the enzyme has multiple binding sites the sites can have an influence on each
other’s binding properties leading to cooperativity and Hill kinetics (s. e.g. [47]).
A random-order kinetic mechanism is the so-called convenience kinetics [103]. The
kinetics reads
v = ET ·
(∏
A
c¯A
c¯A + 1
)
·
(∏
I
1
c¯I + 1
)
·
k+cat
∏
S
c¯
n
S
S − k−cat
∏
P
c¯
n
P
P
∏
s
(
n
S∑
m=0
c¯ m
S
)
+∏
p
(
n
P∑
m=0
c¯ m
P
)
− 1
. (2.24)
and is defined for biochemical reactions with any number of substrates and prod-
ucts. The index variables A, I, S and P run over the sets of activators, inhibitors,
substrates and products of the reaction, respectively. The total concentration of the
enzyme catalysing the reaction is denoted by ET . The variables k+cat and k−cat stand for
the turnover rates of the enzyme in the forward (+) and the backward (−) direction,
respectively. The rescaled concentrations of substrates and products, c¯S = cS/kmS and
c¯P = cP /kmP , are the ratios of the substrate and product concentrations with their Km
values, and for activators and inhibitors, c¯A = cA/KaA and c¯I = cI/KiI , the ratios of the
activator and inhibitor concentrations with their respective dissociation constant, KaA
or KiI . Finally, nS and nP are the stoichiometric coefficients of substrate S and product
P , respectively.
This formula is directly applicable once the stoichiometry of the enzyme-catalysed
reaction and the numbers of activators and inhibitors are known. Effectors enter the
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kinetic formula in Eq. (2.24) as factors only.
The number of kinetic parameters that enter this kinetic expression are one Km value
for each reactant, one Ka value for each activator of the enzyme, a Ki value for each
inhibitor and two turnover rates k±cat for the enzyme. The total enzyme concentration
ET also needs to be known.
The velocity of reaction (2.22) expressed with convenience kinetics reads
v = ET
k+cat
S
KS
− k−cat PQKPKQ
1 + SKS +
P
KP
+ QKQ +
PQ
KPKQ
. (2.25)
2.5 Thermodynamics and Kinetics
Living organisms are open systems. They exchange both matter and energy with their
environment. So laws from classical thermodynamics that concern closed systems do
not apply in the case of living organisms. In fact they maintain their state of high
order, i.e. low entropy, by increasing the entropy of their environment. But equilibrium
thermodynamics still has some consequences for non-equilibrium living systems.
In following the concentrations of species Si will be denoted by ci contrary to the usual
habit in metabolic modelling as S denotes the entropy in thermodynamics.
When considering biochemical processes the Gibbs free energy G is the appropriate
energy as it is a function of the temperature T , the pressure p and the concentration ci
in mols of the species Si the system is composed of:
G = G(T, p, ci) .
If the system variables T , p or ci are modified the Gibbs free energy changes according
to
dG = −SdT + V dp+
∑
i
µidci
where S is the entropy of the system and the µi are the chemical potentials of the species
Si.
For a biochemical reaction in equilibrium at constant temperature T and constant
pressure p the condition
0 != ∆G = ∂G
∂ξ
=
∑
i
niµi . (2.26)
holds, where dci = nidξ and ξ the progress variable or extent of reaction which is
measured in mols. Now for an infinite dilution, i.e. where the activity numerically
equals the concentration, the chemical potential can be written as [72]
µi − µ0i = RT ln[ci] (2.27)
where [ci] is the dimensionless activity on the molarity scale and numerically equal to
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the concentration ci in mols of species Si. In what follows we will write ci instead of [ci].
The quantities µ0i are called the standard Gibbs free energies of species Si.
Single reaction
If Eq. (2.27) is substituted into Eq. (2.26) this results in
0 = ∆G = ∆G0 +RT ln
(∏
i
(ci,eq) ni
)
(2.28)
where
∆G0 =
∑
i
niµ
0
i (2.29)
and ci,eq denotes the concentration in mols of species Si at equilibrium. Eq. (2.28) is
equivalent to
∆G0 = −RT ln
(∏
i
(ci,eq) ni
)
!= −RT lnKeq (2.30)
whereKeq is the equilibrium constant. At equilibrium, the net rate of a reaction vanishes.
∆G = 0 means that
v(ci,eq, p) = 0 . (2.31)
According to Eq. (2.31) equilibrium thermodynamics imposes an algebraical constraint
on the kinetic parameters p. The equilibrium concentrations ci,eq are constrained by the
equilibrium constant in Eq. (2.30). So in general, this will also put constraints on the
parameters p such that Eq. (2.31) is fulfilled.
Reaction network
In the case of a metabolic network with coupled reactions j = 1...N the dependencies of
the kinetic parameter spread over the entire network. For each reaction j at equilibrium
∆G0j = −RT ln
(∏
i
(ci,eq) nij
)
= −RT lnKeq,j (2.32)
and
vj(ci,eq, pj) = 0 . (2.33)
The equilibrium constant Keq in Eq. (2.32) imposes a constraint on the equilibrium con-
centrations of the reaction species ci,eq involved in reaction j of the metabolic network.
By Eq. (2.33) the constraint on the equilibrium concentrations transmits to the param-
eters pj of reaction j. As the reactions of the metabolic network are coupled and some
biochemical species take part in more than one reaction, i.e. a row i of the stoichiometric
matrix N = (nij) has an entry unequal to zero in at least two columns j1 and j2, by
Eq. (2.32) the dependence of the kinetic parameters expands across the entire reaction
network.
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In the field of enzyme kinetics, the equations relating the equilibrium constant of an
enzyme-catalysed reaction and the kinetic parameters of the reaction mechanism are
called Haldane relationships. They depend on the reaction mechanism and therefore on
the model of the reaction. Most Haldane relationships take the general form [126]
Keq =
(
v+max
)m
KP1KP2KP3 ...(
v−max
)m
KS1KS2KS3 ...
(2.34)
where the substrates are denoted by S1,S2,..., the products by P1,P2,... The parameters
KS1 ,..., KP1 ,... are either Michaelis-Menten or dissociation constants and the maximal
velocities in the forward or backward direction are named v+max and v−max, respectively.
The values of the exponent m belong to the set −1, 0, 1, 2, ....
Intuitively, the interpretation of the Haldane relationships is that the different pro-
cesses in the forward and reverse direction involved in enzyme catalysis between the
enzyme, i.e. the binding of substrate to enzyme, the chemical turnover by the enzyme,
the product release, or binding of an inhibitor, have to occur at rates such that at chem-
ical equilibrium the overall rates of the biochemical reaction in the forward and reverse
directions cancel each other out and the equilibrium concentrations satisfy the law of
mass action.
Haldane relationships are useful for checking the consistency of kinetic parameters or
even for accepting or ruling out certain kinetic mechanisms when examining a certain
enzyme [126].
As we will discuss later (s. Ch. 5) they are not only helpful in enzyme assays when
kinetic parameters are measured for an enzyme catalysing a certain reaction. They also
impose constraints in kinetic modelling. Kinetic models of moderate size contain tens of
parameters and require a great effort to be parametrised. In most cases literature data
cannot not be found so that parameter estimation techniques have to serve. Haldane re-
lationships mean that not any parameter combinations can be chosen for the parameters
of a network because they have to fulfil the the Haldane relationship of each reaction in
the network.
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In Sect. 2.4 the phenomenological description of molecular interactions was introduced.
The simplest description of interactions is mass action kinetics. Often kinetics de-
rived from mass action, based on the assumption of fast enzyme-binding are employed.
Michaelis-Menten kinetics is the simplest example of such a derived enzyme mechanism.
Others kinetics have been developed describing more complex enzyme catalysis.
Any kinetic description of cellular processes requires parameters. When processes are
described by mass action a reaction constant k is assigned to each interaction accounted
for in the model (s. Eqs. (2.2) and (2.3)). The Michaelis-Menten description of an
irreversible enzyme-catalysed reaction requires, according to Eq.(2.18), as parameters
the enzyme concentration ET , the turnover rate of the enzyme k2 and the Michaelis-
Menten constant Km.
When a model is constructed, the parameters need to be assigned numerical values so
that the model can serve its purpose. Its dynamics and steady state should be compared
to the biological system and, preferably, novel properties of the system are the outcome
of the modelling that then can be tested experimentally.
The number of parameters in models of metabolic pathways is often quite considerable.
Moderate size models require tens of paramters. A model of glycolysis by Rizzi et al. with
20 reactions uses more than 80 kinetic parameters [128]. In another model of glycolysis,
Teusink et al. include 19 reactions, thereof two at equilibrium and two further described
by constant rates, requiring nearly 60 kinetic parameters [136].
So how are the parameters assigned numerical values such that the kinetics describe
the cellular processes as well as possible? There are three ways of gaining parameter
values. First, the parameters can be measured together with the identification of the
enzyme mechanism. Second, a literature search for enzymes and their kinetics can yield
information on the kinetic mchanism and its parameters. Third, parameter estimation
techniques for the kinetic parameters are employed when in lack of data.
A classical approach to measure enzyme kinetic mechanisms and their parameters are
enzyme assays [105]. In enzyme assays either yield of product or consumption of sub-
strate are measured as a function of time. The measurements are repeated at several
substrate concentrations that are preferably not very large as compared to the Km value
of the substrate in order to avoid saturation of the enzyme. Furthermore so-called initial
velocity conditions are often chosen to maintain the enzyme-substrate complex at equi-
librium. Attention has to be paid to the correct composition of the buffer, its salinity,
its pH, cofactors and effectors. For instance, a Km value which seems unphysiologically
high could have been measured in the absence of an activator of the enzyme present in
vivo. Enzyme assays clarify the kinetic mechanism. And the times series of consumed
substrate or yielded product are used in a non-linear regression done with computers to
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Figure 3.1: The critical Hill coefficient depends on the parameters α, β, and k. The diagram
schematically shows hcrit(α, β, k) as a function of the parameters. The parameters
α, β, and k, represented by the abscissa, are drawn from a random distribtution.
Here the distribution is Gaussian on the logarithmic scale (i.e. log-normal distri-
bution of parameters). By computing the value of hcrit for each instance of the
parameters drawn from the distribution we can sample its distribution (plotted on
the ordinate). If hcrit(α, β, k) were a linear function of the parameters its distribu-
tion would also be a log-normal distribution. This Fig. is from [21]
determine the parameter values. Before computers were common in science, linearisa-
tions like the Lineweaver-Burke plot [47] were employed. But they distort error bars as
well as the intervall between time points which can heavily distort the outcome of the
linear regression.
The second possibility for gaining information on enzyme mechanism and the numer-
ical values of their parameters is literature search. There are also electronical resources
like BRENDA [134] that collect enzyme kinetic data from literature.
Nevertheless, for many enzymes neither the kinetic mechanism nor the parameters
have been characterised experimentally. In this case one has to assume a mechanism
and only estimation techniques can deliver values for kinetic parameters. Assigning
parameters to non-linear kinetic descriptions of network interactions necessarily requires
information that encodes the dynamics of the network. Estimation of kinetic parameters
thus is often based on time series data. For enzyme kinetic parameters for instance,
time series of metabolites are useful. The model output for a certain parameter input is
compared to time series data. In a maximum likelihood estimation, the parameter set
that yields the best approximation to the time series data in an iterative search through
the parameter space will be chosen as the parameters that describe the data best.
26
3.1 Structure, parameters and dynamics
3.1 Structure, parameters and dynamics
Mathematical models of dynamic biochemical processes,
dS
dt
= N · v(S, p) ,
are characterised by the network structure N , the kinetics v and their parameters p.
As discussed earlier on, there are three possible ways of obtaining a parameters p for a
certain interaction: direct measurement, literature search or parameter estimation. In
any case, the parameters are uncertain. Experimental data are subject to measurement
errors. Parameter estimation results, apart from being based on experimental time series,
yields results that depend on the method of scanning the parameter space as well as on
the chosen distance measure. To what extent does dynamic uncertainty of models arise
from the uncertainty in the parameters?
Given the structure N of a network and its kinetics v the dynamical properties can
depend crucially on the values of the parameters. It is of interest to ask how sensitive
the dynamical properties of a network model are with respect to uncertainties in the
parameters. Or stated differently, how robust are the network properties with respect
to changes in the parameters.
For instance, switches that are modelled by sigmoidal signal-response curves, e.g. Hill
curves, have been examined for robustness [19]. Switches can be ultrasensitive meaning
they exhibit a sharp, step-like on-off-profile dependent on the signal strength. A slight
change in signal can make the response switch between two states. Or they can respond
more gradually, the response being growing steadily with stronger signal. In the case of
the Goldbeter-Koshland switch the sensitivity depends on the level of saturation of the
converter enzymes [65], i.e. the ratio of the protein substrate and the Km describing its
binding to the converter enzyme. An ultrasensitive switch is said to robust if its on-off-
profile is maintained upon considerable changes in the parameters of the interactions of
the module. And more generally, a dynamical property of a network is said to be robust
when it is stable with respect to change in the parameters.
Parameters of interactions can change due to mutations of the genes. As kinetic
parameters describe binding and conformational properties of proteins they depend on
the protein structure and can change upon mutations. Moreover, within a population
parameters are distributed due to the genetical heterogeneity of the population. It is
thus of interest to ask how changes in parameters influence the dynamical properties of a
given network. Goldbeter-Koshland switches and MAPK cascades have been examined
in this respect [19].
Dynamical properties of a network depend on the structure of the model, on the
interactions and their kinetic parameters [88]. These properties, e.g. the period of a
model of circadian rhythms, generally cannot be calculated analytically. Consequently,
also the effect of changes in the parameters on the network properties, described by the
so-called sensitivities, cannot be assessed analytically.
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Figure 3.2: The repressilator is a gene regulatory network consisting of three genes inhibiting
one another such that the genes form a closed circuit. The network is modelled by
Eq.(3.1) with a first-order degradation term and a production term dependent on
the presence of inhibitor concentration. The binding of the inhibitor to the gene is
described by a Hill curve, i.e. with increasing hill coefficient the inhibition exhibites
a more pronounced on/off profile dependent on the inhibitor concentration. This
Fig. is from [21]
A way around this problem is drawing parameters from assumed distributions and
calculating the dynamical property. This way we can probe the distribution for the
respective property. These calculations can be interpreted as mimicking gene mutations
that affect parameter values or as representing the genetic spread in a population.
Here we numerically calculate a property a of network for instances of parameters
drawn from a distribution and thus find the distribution of the property itself. If the
distribution of the property is narrow, we conclude that this quantity is strongly de-
termined by the network structure and less so by the parameters itself, at least for
the ensemble of parameters considered. This makes it possible to study which kind of
quantitative and qualitative behaviour is to be expected from the model.
Monte Carlo simulations with random parameters have been used to compute the
distributions of metabolic concentrations, metabolic fluxes, control coefficients, and other
variables [91, 1]. The same approach has been applied to gene regulatory circuits [90]
and a MAP kinase cascade [19].
3.2 The repressilator
Here we focus on the bifurcation point of a network model. We study a simple genetic
network that has been investigated by Elowitz and Leibler [45] called the repressilator
(s. Fig. 3.2). It shows a parameter-dependent transition from a stable steady state to a
limit cycle with persistent oscillations, known as a Hopf bifurcation. The Hill coefficient
in the kinetic equations is the critical parameter. By sampling all other parameters α,
28
3.2 The repressilator
0 2000 4000 6000
50
100
150
200
250
300
350
seconds
n
u
m
be
r o
f m
ol
ec
ul
es
 p
er
 c
el
l
x1
x2
x3
0 2000 4000 6000
50
100
150
200
250
300
350
seconds
n
u
m
be
r o
f m
ol
ec
ul
es
 p
er
 c
el
l
x1
x2
x3
Figure 3.3: Dynamics of the repressilator below and above the Hopf bifurcation. The Hill coef-
ficient h is a bifurcation parameter. For h = 1 < hcrit, the system always tends to
a steady state according to Eq.(3.2), while for h > hcrit, oscillations can arise. The
values of the parameters are: α = 0.001s−1, β = 0.5s−1, k = 100. The critical Hill
coefficient is hcrit ≈2.78. Concentrations are given in molecules per cell. This Fig.
is from [21]
β and k from predefined distributions, we compute the distribution of the critical value
of the Hill coefficient.
The repessilator is a genetic network composed of three genes that form a negative-
feedback loop, each gene repressing the transcription of the gene it acts on. Whereas
Elowitz and Leibler model the system with six dynamical variables, that is three mRNAs
and three proteins, we reduce the model two three variables, the abundances of the gene
products, xi, for genes i = 1, 2, 3.
We further simplify the model by making it symmetric and set the parameters ex-
pressing the interactions equal for each xi. The dynamics are thus modelled by the
differential equations
dxi
dt = −αxi +
β
1 + (xji/k)h
for i = 1, 2, 3 , (3.1)
with h > 0 describing repression and j1 = 3, j2 = 1, j3 = 2 indicating the inhibiting gene
for genes i = 1, 2, 3. The parameter α describes the rate of degradation and β the full,
unhindered transcription. The effect of the genes on each other is described by a Hill
signal response-function with dissociation constant k and the Hill coefficient h.
For the symmetric repressilator, modelled according to Eq.(3.1) with h = 1, the steady
state can be calculated analytically. It reads
xi =
√
kβ
α
+ k
2
4 −
k
2 . (3.2)
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Figure 3.4: Three of the four plots show histograms of the distributions the parameters α, β
and k were drawn from. The mean values correspond to α¯ = 0.001s−1, β¯ = 0.5s−1,
and k¯ = 100. The width was in each case σ = 0.01. The bottom right plot shows
the histogram for the resulting distribution of the value hcrit. This Fig. is from [21]
The genetic interaction described by a Hill curve
1/(1 + (xi/k)h) (3.3)
describes a repressor for h > 0 and an activator for h < 0. For |h| = 1, it turns into
the normal Michaelis-Menten curve. For |h| > 1, the signal-response curve becomes a
sigmoid with inflection point
k h
√
h− 1
h+ 1
lying between 0 and k. As the Hill signal-response curve (3.3) takes values between 0
and 1 and is strictly monotonic, we measure the width of the switch by the length of the
interval in which the curve falls from 0.9 to 0.1. It is calculated to be
x0.1 − x0.9 = k
∣∣∣∣∣ h
√
0.9
0.1 −
h
√
0.1
0.9
∣∣∣∣∣ .
The width is proportional to k and declines with h. For constant k, the signal-response
becomes more switch-like with larger h.
Given values for α, β, and k, this system can undergo a Hopf bifurcation at a certain
value h = hcrit(α, β, k): for values h < hcrit, the system reaches a stable steady state,
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Figure 3.5: Correlation plots for the three parameters α, β and k versus hcrit. The log-normal
distributions for α, β and k with mean values corresponding to α¯ = 0.001s−1,
β¯ = 0.5s−1, and k¯ = 100 and the width σ = 0.01. In the top left corner of the plots
the correlation coefficient is displayed. The bottom right plot shows the strong
correlation between lnα− lnβ + lnk and hcrit. This Fig. is from [21]
while for h > hcrit, the steady state becomes unstable and a stable limit cycle shows up
(s. Fig. 3.3). For the values α = 0.001s−1, β = 0.5s−1, k = 100, we find hcrit ≈ 2.78.
Concentrations are measured in molecules per cell.
3.3 Distribution of a bifurcation parameter in a genetic
network with uncertain parameters
The parameters α, β, and k were drawn from log-normal distributions such that log10 α,
log10 β, and log10 k are independent and normally distributed with a standard deviation
of σ and mean values corresponding to α¯ = 0.001s−1, β¯ = 0.5s−1, and k¯ = 100, respec-
tively. We performed 10000 simulations for distributions with widths both σ = 0.01 and
σ = 0.2. Drawing sets of parameters from these distributions we obtain instances of the
dynamic system with undetermined Hill coefficient h. We then let the hill coefficient
vary for each such realisation by running a bifurcation analysis to determine the critical
value hcrit(α, β, k) of the Hill coefficient.
For a distribution width of σ = 0.01 we were able to determine the bifurcation point
for each instance drawn from the distribution. Fig. 3.4 shows histograms of the random
parameters α, β and k as well as the resulting histogram for hcrit. In 104 simulations,
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Figure 3.6: Three of the four plots show histograms of the distribution the parameters α, β
and k were drawn from. The mean values correspond to α¯ = 0.001s−1, β¯ = 0.5s−1,
and k¯ = 100. The width was in each case σ = 0.2. The bottom right plot show the
histogram for the resulting distribution of the value hcrit.
no critical value lower than ∼ 2.68 was found. The correlation between the individual
parameters and hcrit is shown in the (logarithmic) scatter plots in Fig. 3.5. We find
positive correlation values for α and k, respectively, while β is negatively correlated with
hcrit. This shows that a lower damping (small α) and a stronger coupling (high β or
low k) between genes makes the system more prone to oscillations.
For a parameter width σ = 0.2 we found a bifurcation point in 9779 out of 10000 sim-
ulations. Figs. 3.6 and 3.7 show the the parameter histograms, the resulting histogram
for hcrit and the correlations plots. The lowest value hcrit we found was ∼ 2.09.
The qualitative behaviour of the cycle does not depend on the absolute scaling of time
and concentration. This implies that hcrit can only depend on the linear combination
lnα− lnβ + lnk which is confirmed by our simulation results (s. Figs. 3.5 and 3.7).
Parameter estimation for complex dynamic models is a challenge in current systems
biology. To study the potential dynamic behaviour of a given model with uncertain
parameters, we use a Monte-Carlo sampling approach. We draw the parameters from a
distribution and observe the distribution of a property of the system.
In the example model describing a small genetic network, the occurrence of a Hopf
bifurcation leading to qualitative change of the dynamic behaviour and the distribution
of the connected quantity, the critical Hill coefficient, have been determined. We may
also ask a slightly different question: if all parameters (including the Hill coefficients) are
drawn from distributions, what is the probability for the system to oscillate? Given our
distribution of hcrit, this can be easily answered by sampling h and hcrit independently
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Figure 3.7: Correlation plots for the three parameters α, β and k versus hcrit. The log-normal
distributions for α, β and k with mean values corresponding to α¯ = 0.001s−1,
β¯ = 0.5s−1, and k¯ = 100 and the width σ = 0.2. In the top left corner of the plots
the correlation coefficient is displayed. The bottom right plot still shows that hcrit
is a function of lnα− lnβ + lnk.
from their distributions and counting how often h > hcrit .
The presented analysis can be considered as first step towards a thoroughly parame-
terized model. It gives hints about which types of qualitative behaviour can be expected
at all and at what constellation of parameter values. It assesses which parameter values
have a strong influence on the dynamics. This in turn is helpful in pointing to parts
of the model where further more precise measurements are necessary. It clarifies where
fluctuations might have a strong impact and they can be disregarded.
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4.1 Parametrising models
The purpose of any model of a biological network is, first of all, to reproduce known
facts about a biological system. As we saw in the last chapter, the values of the kinetic
parameters of a model can have significant influence on the dynamical behaviour of a
model. Thus, reproducing facts means finding the correct parameters such that the
model behaves as expected. When during model construction kinetic parameters lack,
time series of cellular components are used for parameter estimation, searching that set
of parameters that best reproduces the time series.
But a satisfactory model will even go further and be used to make predictions about
the system. These are then checked by experiments. Discrepancies between model and
experiment, in turn, requires model revising followed by further experimental verifica-
tion. This iterative cycle of model revision and experimental verification constitutes the
cycle of mutual refinement of experimental and modelling knowledge about a biological
system.
Model predictions concern properties of the systems that arise from the non-linear in-
teraction dynamics of the model [11, 93]. Predictions include insight through simulation
into the relative importance of components or modules in achieving a certain function.
Furthermore, physiological malfunction or genetic defects can be mimicked by enhancing
or weakening specific fluxes or rates associated with the respective proteins.
Model predictions and reproduction of known facts can only be achieved with cor-
rect parameter values. When possible, these values come from experiments that were
undertaken under those conditions that the model is supposed to simulate. Another
way of assigning values to kinetic parameters is searching the literature and electronical
resources like BRENDA [134] for retrieval of kinetic data. These sources should also
give the kinetic mechanism of interactions.
But in many cases information on the kinetic mechanism of an enzyme, in a specific
organism or organelle, as well as the appropriate parameters are not available. Modellers
then have to resort to other means and ways of parametrising their models, like making
educated guesses.
As mentioned earlier, one way of dealing with the lack of kinetic parameters is using
time series data of components of the system for parameter estimation purposes. Hereby,
kinetic mechanisms have to be assumed unless further knowledge about the enzyme or
protein complex can be taken into account. Another heuristic way of knowledge-based
guessing of kinetic and cellular parameters is searching for information about the same
enzyme or protein complex in closely related organisms [2].
Not only kinetic parameters, information about protein and metabolite concentrations
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also is of use for metabolic modelling, because modelling with differential equations (s.
Eq. (2.4)) requires initial values of the concentrations of the components.
4.2 Data sources of parameters
For the purpose of assigning numerical values to parameters of metabolic models we have
thus collected three types of data from a variety of sources. First, data for cellular abun-
dances or concentrations of proteins, mRNA and metabolites serve to set or reasonably
guess initial values of concentrations in the model. Second, data of kinetic parameters
are needed for the kinetics of the enzyme catalysed reactions. Third, thermodynamic
data, impose constraints on the kinetic parameters and thus introduce dependencies
between them (s. Sect. 2.5).
Concentrations of cellular components
(1) We take metabolite concentrations from Albe et al. [2]. In this publication con-
centrations of enzyme substrates are calculated from values for metabolite concen-
trations per weight of dry or fresh tissue and the water content of the respective
fresh tissue, collected in a literature survey. The metabolite concentrations con-
tain values for species covering three kingdoms: Escherichia coli, Saccharomyces
cerevisiae, Dictyostelium discoideum, Homo sapiens, Rattus sp., Oryctolagus cu-
niculus, Vigna radiata. The tissues are liver, muscle and heart for rattus sp., red
blood cells for Homo sapiens and Oryctolagus cuniculus, seeds for Vigna radiata.
For each concentration value the metabolite name and the organism as well as the
tissue are given.
(2) We included three sources for protein abundance data. The first contains mea-
sured abundances. The two other publications, comparing protein abundance and
mRNA expression for the yeast Saccharomyces cerevisiae, provide computed pro-
tein abundance data by integrating data for protein and mRNA abundance from
several experimental sources.
Ghaemmaghami et al. [58] measured protein abundances by Western blot analysis
for a TAP-tagged fusion library of the yeast Saccharomyces cerevisiae grown in
rich medium to log-phase. The abundances are available at the Yeast GFP Fusion
Localization Database [120] and are enhanced by localisation information [75].
Greenbaum et al. incorporate two-dimensional electrophoresis and multidimen-
sional protein identification technology (so-called MudPit) data sets into their
study [68]. They map each of the protein data sets independently into mRNA
space by calculating a non-linear transformation onto a reference data set of mRNA
abundances. By using the inverse of the calculated transformation of one of the
protein datasets chosen by the authors, the resulting computed mRNA data sets
are then transformed back into protein space (for details s. [67]).
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Beyer et al. [16] combine the computed reference protein data set from [68] and
the experimental data from [58] by taking the arithmetic mean if both data sets
provide a value for an ORF, and the value from the respective source if only one
is present. For the proteins that have a value in both data sets there often is
considerable difference in order of magnitude between the values of the sources (s.
supplemental material of [16]).
Each of theses sources gives the abundance value and the ordered locus name of
the gene and, if existent, the gene name.
(3) Genome-wide mRNA abundance data for yeast wild-type cells, the yeast transcrip-
tome, grown in YPD (Yeast extract peptone dextrose) medium under log-growth
conditions without any stressors or chemical agents are found in [16, 73].
Holstege et al. measured the abundances with high-density oligonucleotide arrays
(HDA) that allow for absolute measurements of abundances in the range from 0.1
to several hundred mRNA copies per cell [146].
Beyer et al. compile an mRNA expression data set from seven publications (s.
supplemental material of [16]). Each data set is normalised to 15000 mRNA
molecules per cell [146]. For each gene the reference value is chosen to be the
median value among the data sets. Finally, the data are corrected for saturation
(s. supplemental material of [16]).
In all sources the abundance value is associated with the ordered locus name (OLN)
and, if existent, the gene name of a protein coding sequence.
Kinetic parameters
(4) KM values are obtained from the public database BRENDA [134, 130, 131]. The
KM values in BRENDA are collected from the literature. At the top level all data
in BRENDA are classified by the EC number but can also be searched by other
criteria. Organism, substrate, if possible experimental conditions, isoenzymes and
presence of activators, and a literature reference are given. In most cases a PubMed
identifier [113] can be revealed behind the literature reference.
Enzyme naming complies to the IUBMB (International Union of Biochemistry
and Molecular Biology) standards. Organism names are taken as they are from
the literature sources if they lack systematic names. Reaction names are as defined
by the IUBMB. Substrate names are those found in the literature.
(5) KI values are obtained from the public database BRENDA [134, 130, 131]. They
are complemented by the inhibitor name, organism name, a commentary about
experimental and assay conditions. The literature reference is given.
(6) kcat values are obtained from the public database BRENDA [134, 130, 131]. They
come with information about the converted substrate, the organism, experimental
conditions, as well as the literature reference.
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Data for parameters and their sources
parameter data source
concentrations of components
metabolite concentration [2]
protein abundance [120, 16, 67]
mRNA abundance [73]
kinetic parameters
KM values [134]
KI values [134]
kcat values [134]
transcriptional frequency [73]
mRNA half-life [73]
thermodynamic constraints
equilibrium constant [63]
Gibbs free energy of formation [3, 71]
Table 4.1: For modelling kinetic models of metabolic networks, different types of data serve
to assign values to the parameters of a model. Three types of parameters come
into play in kinetic modelling. First, concentrations of biomolecules serve to make
reasonable assumptions about initial values of the biomolecules involved in the model,
i.e. metabolites, mRNAs and proteins. Second, parameters for enzyme kinetics have
to inserted into the kinetic expressions of the rates of each single enzyme catalysed
reaction in the metabolic network. Third, thermodynamic data impose constraints
onto the kinetic parameters throughout the whole metabolic network.
(7) Transcriptional frequencies for the yeast Saccharomyces cerevisiae come from [73].
They are calculated from steady state mRNA abundances and the half-lives deter-
mined from mRNA abundances in a temperature-sensitive mutant (s. (4.2).
(8) Half-life data for mRNA transcripts in the yeast Saccharomyces cerevisiae are
available from [73]. They are computed from the mRNA expression levels in a
temperature sensitive mutant strain of the yeast Saccharomyces cerevisiae, rpb1-1,
45min after a shift to a non-permissive temperature of 37◦C. At this tempera-
ture the temperature-sensitive mutants immediately shut down the transcription
of protein-coding genes and only degradation affects the mRNA levels. By compar-
ing the mRNA levels in the mutant to those in wild type after 45mins, an apparent,
first-order half-life is calculated.
Thermodynamic data
(9) Apparent equilibrium constants, K ′eq, of biochemical reactions are available at the
public database TECRDB(Thermodynamics of Enzyme-Catalysed Reactions) [63,
62]. The data in the database are retrieved from a literature search. Besides the
reference itself, the following information is given with the apparent equilibrium
constants if found in the reference source: reaction, enzyme, method of measure-
38
4.3 Annotation of parameter data
ment, conditions of measurement (temperature, pH, ionic strength, buffers, co-
factors). The quality of the data are assessed and sometimes a commentary is
added.
Apparent equilibrium constants K ′eq are used to calculate the transformed Gibbs
free energies of reaction
∆G′0 = −RT lnK ′eq
for biochemical reactions that account for sums over different ionised forms of a
reactant [4]. When the pH and, in some cases, free concentrations of certain metal
ions are given, it is the transformed Gibbs energy of reaction that is the criterion
of equilibrium and that determines the apparent equilibrium constant [4]. The
apparent equilibrium constant K ′eq for a biochemical reaction is written in terms
of sums of species.
For the case of hydrolysis of ATP to ADP, the biochemical reaction occurring at
a certain pH and pMg is expressed as
ATP + H20⇀↽ ADP + Pi (4.1)
with Pi denoting orthophosphate. In this reaction, ATP stands for a mixture of
ATP4−, HATP3−, H2ATP2−, MgATP2−, MgHATP− and Mg2ATP at equilibrium.
This holds for ADP analogously. The apparent equilibrium constant then is [4]
K
′
eq =
ADP Pi
ATP c0 . (4.2)
with c0 the standard state concentration of 1M.
The TECRDB follows the recommendations for biochemical thermodynamics by
the IUPAC (International Union of Pure and Applied Chemistry) [4, 115] and the
nomenclature of biochemicals by the IUBMB.
(10) Standard Gibbs free energies of formation of biochemical species are found in [3,
71]. They refer to biological standard conditions, namely a pH value of 7 and a
temperature of 298.15K. Both references provide computed Gibbs free energies of
formation.
4.3 Annotation of parameter data
The collected data for kinetic parameters and concentrations of cellular components
are useful for modelling purposes only if each experimental value is fully annotated
and can be associated with its meaning in the mathematical encoding of a model. A
human modeller can then integrate information from different resources of knowledge to
manually put together a model of a metabolic network.
But with systems biology the need for electronical exchange of biological knowledge,
of experimental data for cellular components and their interactions, as well as of models
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has grown. The various types of knowledge, the biological network information and
experimental data, that enter a mathematical model of a biological network need to
be linked to each other. There is a hierarchy in the way these heterogeneous types of
information refer to each other.
At the basis of this hierarchy is the biological knowledge. In recent years electronical
resources containing knowledge about the biological networks have been built. These
pathway databases contain knowledge about cellular components and the networks they
form. They represent inventories of the components of the cell as well as the struc-
ture of the cellular networks. KEGG (Kyoto Encylopedia of Genes and Genomes) is a
prominent example of a pathway database [85, 99] linking genomes to pathways and
including biochemical reactions. Other pathway databases are Reactome [140, 124]
and BioCyc [87, 81]. ChEBI (Chemical Entities of Biological Interest) is a resource
of biochemical compounds confining itself to the so-called small molecules in contrast to
genome-encoded macromolecules and classifies them according to their biological func-
tion and their structure [42].
At the next level are resources containing the data for concentrations of cellular com-
ponents and the kinetic data describing their interactions. Each data has to be asso-
ciated with the knowledge that allows for its interpretation in terms of the biological
network and its interactions. Electronic resources with data for biological networks are
the BRENDA [134] or the Yeast GFP Fusion Localization Database [120].
Finally, dynamic models of biological networks refer to both resources of information,
to the biological knowledge about components and interactions as well as to the data
reflecting their dynamics. In order to achieve the electronical integration of data and in-
teroperability of resources for modelling, shared standards for knowledge representation
and nomenclature are needed and have to be agreed upon. The resources need to speak
the same biological language.
To be of use in knowledge integration for the construction of metabolic networks, the
data of concentrations of components and for enzyme kinetics have to be annotated with
the appropriate information (s. Tbl. 4.2).
(1) Data of concentrations of cellular components have to identify the respective com-
ponent and the organism they were measured in.
(2) As enzymes catalyse metabolic reactions, data for enzyme kinetic parameters nec-
essarily have to refer to the enzyme, the reaction, and the organism they were
measured in. Additionally, turnover rates kcat are, in the case of a reversible pro-
cess, meaningful only when the direction of the reaction they refer to is known.
For Km value data we also need to know the respective substrates. In the case of
data for Ki values the inhibitor name is required.
(3) In the case of data for kinetic parameters describing mRNA transcription frequency
and half-life as first-order processes, the ORF and the organism have to be denoted.
(4) Thermodynamic data merely regard biochemical reactions. Thus data for equilib-
rium constants refer to a reaction, and data for Gibbs free energies of formation
concern metabolites.
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Information required for data completeness
parameter metabolite enzyme reaction gene organism
metabolite concentration × ×
protein abundance × ×
mRNA abundance × ×
Km values × × × ×
KI values × × × ×
kcat values 1 × × × ×
transcriptional frequency × ×
mRNA half-life × ×
equilibrium constant ×
Gibbs energy of formation ×
Table 4.2: The data for model parametrisation are the dependent entities of the database. An
entry in the respective table is complete only if additional information, as represented
by the crosses (×), is associated with a sample of the respective data type. 1The
metabolite is used to identify the direction of the reaction.
4.4 Biological standards for model parameters
Data useful for parametrising models of metabolic networks are found in the literature
and databases (s. Tbl. 4.1 in Sect. 4.1). These data, according to their type, are anno-
tated with instances of one or several of the following biological concepts (s. Tbl. 4.2):
1. metabolite,
2. reaction,
3. enzyme,
4. gene,
5. organism.
In general, the annotation found in literature does not agree with the according bi-
ological information as stored in electronical resources. The main reason is that no
consistent nomenclature is used.
For instance, names of biochemical compounds come in a variety of ways. Many sub-
stances have several common names that are traditionally used in biology. These can
be ambiguous and are often used in various forms regarding, for instance, the inclusion
of isomer and stereoisomer prefixes. The IUPAC has recommended a chemical nomen-
clature [114] that sometimes leads to unwieldy names and thus is not generally used in
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practice. Resources like KEGG LIGAND or ChEBI, on the contrary, are dictionaries of
small molecular entities in biochemistry giving not only a single name but also synonyms
and spelling variants of the entities. The names are often the trivial names traditionally
used in biology that also serve in describing enzyme reactions.
A knowledgeable human reader with the appropriate background will generally man-
age to link the information that comes with experimental data to electronical resources.
But electronical assignment will in many cases not be sucessful. Mapping of the data
from literature to the information stored in the electronical resources often encounters
difficulties because string comparison requires exact matching. Stored synonyms, of
course, enhance the chance of identification by string comparison.
Here we present an effort to map existing data useful for model parametrisation onto
several reference resources chosen as standards. KEGG was chosen as a standard for
naming compounds and reactions. Enzymes are classified according to the EC (Enzyme
Commission) numbers [116]. ORFs are given with their systematic locus tags (also called
systematic names, ordered locus names, OFR names) that are location-based systematic
names assigned to genes in sequencing projects. Organisms are mapped onto the NCBI
Taxonomy [55].
The data will thus be connected to and annotated with standard resources making
them usable for computer tools and giving meaning to them within kinetic models of
metabolism. Compounds and reactions from KEGG, EC numbers, locus tags from
genome sequencing projects and organism names from the NCBI Taxonomy represent
knowledge about the biological entities needed to describe processes of metabolism.
4.5 Standard references for model parameters
4.5.1 KEGG as a standard for metabolites and reactions
KEGG (Kyoto Encyclopedia of Genes and Genomes) is a resource that was built to link
genomes to biological function with the aim of reconstructing biological systems based
on deciphered genomes [117]. The KEGG resource is an electronical representation of
the molecular biology and biochemistry of the cell. Three of the databases making up
the KEGG resource are: GENES, LIGAND, and PATHWAY.
(i) The database GENES contains complete and partial genomes generated from pub-
lic resources, mainly the database RefSeq [125, 54] beside other sources like Gen-
Bank [15, 112] and EMBL [97, 80].
The collected genes are assigned KEGG orthology (KO) identifiers. The KO sys-
tem is a categorisation of ortholgous genes that captures a gene’s function based
on pathways or protein networks [85, 86]. The KO consists of four levels. The
top level contains five categories: metabolism, genetic information processing, en-
vironmental information processing, cellular processes and human diseases. The
third corresponds to pathways and protein interactions, the fourth to genes. About
one third to half of the genes contained in KEGG GENES have assigned a KO
term [106].
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(ii) The database LIGAND contains tables with key players of biochemistry: metabo-
lites and enzymes and how these interact through biochemical reactions. They are
stored in the databases COMPOUND, REACTION and ENZYME. Recently the
database LIGAND was enhanced by tables for glycans and drugs. More specifically,
KEGG COMPOUND is a chemical structure database for metabolic compounds
and chemical substances relevant to biology. KEGG REACTION contains those
reactions defined by the IUBMB (s. Sect. 4.5.2) as well as additional ones. For
instance the enzyme alcohol dehydrogenase with EC number 1.1.1.1 is defined to
catalyse the reaction an alcohol + NAD+ <=> an aldehyde or ketone + NADH
+ H+. But in KEGG, the enzyme 1.1.1.1 is associated with further reactions that
actually appear in metabolic pathways with, for instance, the alcohol and the
aldehyde specified as ethanol and acetaldehyde (R00754).
(iii) The database PATHWAY collects maps of networks of gene products or generalised
protein networks. These generalised protein networks contain direct and indirect
protein-protein-interactions [83, 84].
Direct protein-protein-interactions are found in protein complexes (e.g. RNA poly-
merase) or signalling pathways. Metabolic networks (mediated by the metabo-
lites being shared between enzymes) and gene regulatory networks (mediated by
the bound DNA producing its protein product) represent indirect protein-protein-
interactions.
The five main categories of protein interaction networks in the PATHWAY database
are metabolism, genetic information processing, environmental information pro-
cessing, cellular processes and human diseases. The pathways are manually drawn
based on literature and persistently updated according to biochemical evidence.
4.5.2 EC classification for enzymes
The EC (Enzyme Commission) nomenclature [142, 116] is chosen as a standard for
enzymes. It classifies enzymes according to the catalysed reaction.
4.5.3 Ordered locus names for genes
As standard identifiers for genes ordered locus names (OLNs) are used.
In completely sequenced genomes generally not every gene is characterised and given
a name. But during a sequencing project they are all systematically assigned OLNs that
encipher the position of every, also the uncharacterised genes relative to each other in
the chromosome space. They are not gene names but location holders identifying the
locus.
OLNs are also called locus tags or systematic names. They are used in resources like
RefSeq [54], SGD [123] or UniProt [36].
For the yeast Saccharomyces cerevisiae, for instance, an example of an ordered locus
name is YLR113W. It denotes the gene with the name HOG1. The OLN encodes the
location of an ORF in the following way [40]:
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1. ’Y’ stands for yeast.
2. The second letter, one out of ’A’, ’B’, ..., ’P’, letter means one of the sixteen
chromosomes.
3. The third letter, ’R’ or ’L’, stands for the right or left arm of the chromosome.
4. The three-digit number corresponds to the order of the ORF counting from the
centromere.
5. The last letter, ’W’ or ’C’, designate the Watson or the Crick strand.
4.5.4 NCBI Taxonomy for organisms
The NCBI taxonomy database [55] is used as a standard reference for organisms. It con-
tains more than 240 000 named organisms that are found with at least one sequence [144]
in GenBank. Every new sequence submission to GenBank is checked for new organisms
that are then classified and added to the taxonomy. The classification is based on phy-
logeny representing evolutionary relations as well as on morphological data.
4.6 Database entities
Once the data for parameters of kinetic models of metabolism are annotated with stan-
dard references, a database can be set up. Each parameter type (s. Tbl. 4.1) constitutes
a table of the database. In addition, every biological concept used for parameter annota-
tion stands for a table (s. Sect. 4.4). The tables containing the data for the parameters
refer to the tables representing the biological concepts (s. Tbl. 4.2).
Databases are commonly represented by the entity-relationship (ER) model [27]. The
information contained in a database is structured by the help of entities and relationships
between them.
Entities represent abstract objects or concepts. They can be thought of as nouns. In
a database they correspond to tables where each entry of the table is an instance of the
respective entity. Usually the entries are said to be the rows of the table. The columns
correspond to the attributes that define the concept.
For example, in the KEGG database the table REACTION contains instances of the
concept ’reaction’ one of which is the entry R00200 with the definition ATP + Pyruvate
<=> ADP + Phosphoenolpyruvate. Two attributes of this entry, the identifier and the
biochemical definition, are mentioned here. Each entry (row) in the table REACTION
has several attributes (columns) the values of which describe that specific instance.
Relationships, on the other hand, connect two or more entities and can be regarded
as verbs. They correspond to a column in one table that contains references to another
table. For the last example from KEGG REACTION, the entry identified by R00200
has references to those entries in the table COMPOUND which have the names ATP,
Pyruvate, ADP and Phosphoenolpyruvate, respectively. The verb that describes the
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relationship between the tables REACTION and COMPOUND can be thought of as
’consumes or produces’.
Entities fall into two groups, independent and dependent ones. Independent entities do
not rely on other entities to be identified and semantically complete. Instead, dependent
entities can only be completely specified by reference to at least one other entity. For
example, a reaction is identified only if the involved metabolites are so. Thus the entity
reaction depends on the entity metabolite.
In an electronical resource containing data for model parameters, the biological con-
cepts make up the entities the data refer to. Thus, the biological entities constitute the
independent entities, gene being an exception. A gene, as a nucleotide sequence, is part
of the genome of an organism and thus refers to the concept of organism.
The concepts corresponding to the parameters of kinetic models refer to the com-
ponents and interactions of the biological network. These entities are thus dependent
on the biological ones. For instance, a Km value in the Michaelis-Menten formula (s.
Eq.(2.18)), describing the turnover velocity of an irreversible biochemical reaction in the
metabolism of an organism, is fully identified only if information on the substrate, the
enzyme and the reaction as well as the organism is given (s. Tbl. 4.2).
4.6.1 Biological entities
The biological entities, covering the different levels from the genome to metabolism, onto
which the data will be mapped are (s. Sect. 4.4):
1. metabolite,
2. reaction,
3. enzyme,
4. gene,
5. organism.
The entities metabolite and reaction are biochemical. The entities gene and organism
belong to domain of evolutionary biology where organisms are genetically related to each
other. The gap between these two realms is bridged by the entity enzyme which belongs
to both owing to its being a gene product and a catalyst of a biochemical reaction.
The interconnections between the biological entities are drawn in Fig. 4.1. They can be
captured by a phrase of the following type: The increased expression of gene YKL060C
of Saccharomyces cerevisiae leads to higher levels of the enzyme Fructose-bisphosphate
aldolase augmenting the flux through the catalysed reaction F1,6BP⇀↽ DHAP+GADP.
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Figure 4.1: The biological entities as represented by their tables in the database and the in-
terrelations between them. The biological entities cover genomic (entities organism
and gene) and biochemical information (entities metabolite and reaction) that is
linked by the entity enzyme.
4.6.2 Unit and reference entities
The data for parameters of kinetic models need not only to be annotated with biolog-
ical knowledge. Each parameter type is measured in its unit. Furthermore, data for
parameters refer to sources they were published in.
In order to simplify the structure of tables and their maintenance, we have scaled
every data type to a single unit. In the literature data often come in a variety of units.
The data thus refer to two further entities:
1. unit,
2. reference.
4.6.3 Data entities
Each data type for parameters of kinetic models of metabolism amounts to a separate
entity of the database (s. Tbl. 4.1). Each of these entities relates to one or several of
the biological entities according to Tbl. 4.2.
1. metabolite concentration
2. protein abundance
3. mRNA abundance
4. Km values
5. Ki values
6. kcat values
7. transcriptional frequency
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8. mRNA half-life
9. equilibrium constant
10. Gibbs free energy of formation
4.7 Database tables
The entities translate directly into tables of the database. Independent entities corre-
spond to tables that do not refer to other tables. Tables standing for dependent entities
contain columns with references to other tables.
4.7.1 Independent tables
1. metabolite,
2. reaction,
3. enzyme,
4. organism,
5. unit,
6. reference.
The independent tables correspond to concepts that are self-explanatory or explained
elsewhere. Here the independent entities all refer to existing knowledge resources that
were chosen as standards.
They are the following: KEGG serves as a standard for metabolite and reaction.
The EC nomenclature is the standard for enzyme. OLNs (ordered locus names) used to
denote ORFs in resources like RefSeq [54], SGD [123] or UniProt [36] denominate the
entries of the table gene. The reference for organism is the NCBI taxonomy.
As to the non-biological entities, the table unit comprises standard SI units for each
parameter type, and reference indicates the source of the data, either a literature or
database reference.
4.7.2 Dependent tables
Among the dependent tables there is one biological one, namely gene. The other depen-
dent tables contain the data to be used for model parametrisation. The entries in the
corresponding table of each dependent entity will consist in a value for that quantity
and references to the appropriate entries in the tables of the independent entities. The
dependent entities are the following:
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1. gene,
2. metabolite_concentration,
3. protein_abundance,
4. mrna_abundance,
5. km,
6. k_mod,
7. kcat,
8. transcriptional_frequency,
9. mrna_half_life,
10. equilibrium_constant,
11. formation_enthalpy,
where k_mod is designed to comprises both inhibition constants Ki and activation con-
stants Ka.
4.7.3 Associative entities
The tables
1. map_enzyme_reaction,
2. map_gene_enzyme,
3. map_reaction_metabolite
constitute mappings between the entities metabolite and reaction, gene and enzyme,
reaction and metabolite, respectively. These mappings are many-to-many meaning
that a single entry in one table can refer to several entries in the other table, and vice
versa. The information in these tables was extracted from KEGG.
In the case of reactions and enzymes, for example, there can be multiple forms of an
enzyme that catalyse the same reaction like isoenzymes (derived from different genes).
On the other hand there are enzymes that catalyse several reactions using either the
same catalytic centre or, in the case of multienzymes, different parts or subunits.
4.8 Structure of Tables
Tables containing biological hierarchies
The tables of the basic (independent) biological entities have a simple structure (s.
Tbl.(4.3)). They contain:
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The biological tables of the database
table reference id reference name
metabolite KEGG COMPOUND id KEGG COMPOUND name
reaction KEGG REACTION id KEGG REACTION name
enzyme EC number official IUBMB name
organism NCBI Taxonomy id NCBI Taxonomy standard name
gene 1 OLN common name if existent
Table 4.3: The tables containing the biological knowledge used for data annotation all refer to
chosen standards. These standards constitute inventories of the corresponding entity
in the biological universe. Each instance fills a row of the table, the columns of the
table contain the identifier or the name of the respective instance. For each entity
the identifier and name of the biological object as given in the standard references
were adopted here.
• an internal identifier as the primary key,
• an identifier from an external reference source taken as a standard; the KEGG
identifier (in the case of metabolite, reaction), the identifier of the NCBI Tax-
onomy database [55] for organism, the EC number [18, 116] for enzyme,
• and the name given in these sources; i.e. the KEGG metabolite name is used for
metabolite, the KEGG reaction string for reaction, the NCBI Taxonomy stan-
dard name for organism and the official name according to the IUBMB nomen-
clature for enzyme.
The data related independent entities have the following structure. The table unit
has an internal identifier as primary key and columns for the unit name and the physical
quantity it stands for. The table reference has, besides the internal identifier, simply
a column for the reference name.
Tables containing data
The tables that contain the data for the kinetic parameters, concentrations and thermo-
dynamic quantities all contain
• an internal identfier as the primary key,
• the value,
• possibly an error or standard deviation,
• references to the biological tables in order to interpret the data correctly and in a
meaningful way (s. Fig.(4.2) and Tbl(4.1)).
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Number of data entries inserted into tables
table no. of entries no. of original data
metabolite_concentraton 225 225
protein_abundance 10,141 10,141
mrna_abundance 12,267 12,267
km 47,449 76,427
k_mod 5,728 14,446
kcat 10,976 22,291
transcriptional_frequency 4,994 4,994
mrna_half_life 5,257 5,257
equilibrium_constant 2,088 3,409
formation_enthalpy 9,696 9,696
Table 4.4: Statistics of the data tables. The number of data entries For the enzyme kinetic
parameters the number of values found by text mining is also given.
4.9 Constructing the database
The database containing the data for parametrising kinetic models of metabolic networks
is set up with the MySQL database management system. Data were collected from the
sources given in Sec. 4.1.
In order to insert the data into the database and make them electronically accessible,
each single data point has to be annotated with the appropriate biological knowledge,
represented as entries in the database. Every measured parameter has a meaning in the
context of dynamical models of biological networks. What meaning it has in the interac-
tion network is determined by its definition and is specified by naming the components
of the biological network it relates to.
The biological information coming with the data has to be mapped to the biological
information that is stored in the database chosen to be the naming standard. The
mapping is done by comparison, by string comparison of the information in the source
against that in the database.
If the data in the source are already annotated with standard names or identfiers there
is no work to do anymore. For some of the data sources given in Tbl. 4.1 this is the
case. Which information is required for annotation of which type of parameter shown in
Tbl.(4.2).
1. Into the database table metabolite_concentration 225 metabolite concentra-
tions were included. All concentration values were annotated with the appropriate
entry in each of the tables metabolite and organism.
2. We entered more than 10,141 abundance values measured for 4,237 proteins of
the yeast Saccharomyces cerevisiae into the table protein_abundance. As these
data came with ordered locus names they were readily inserted into the database
without any loss.
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3. More than 12,267 mRNA abundances measured for 6,208 mRNAs of the yeast Sac-
charomyces cerevisiae could be entered into the database table mrna_abundance.
As in the case of protein abundance data, the mRNA abundances had been an-
notated with standard ordered locus names and could be completely used for the
database.
4. By far the largest amount of data for a parameter type is found for Km values.
These come from BRENDA [134]. 47,449 entries out of 76,427 in total were entered
into the table km and could be mapped simultaneously onto an entry of the tables
enzyme, metabolite and organism. Of these, 21,538 could also be assigned an
entry of the table reaction.
We also included 14,290 values from an effort of gaining knowledge about kinetic
parameters from PubMed abstracts [70]. All of these are annotated by entries of
the tables enzyme, metabolite and organism. Of these, 9,349 are also associated
with an entry from the table reaction.
5. 5,728 Ki values from BRENDA [134] were inserted into the table k_mod. These
could each be mapped to entries in the tables enzyme, metabolite and organism.
2776 of these could be mapped to an entry of reaction. The original data contain
14,446 Ki values.
Text mining PubMed abstracts for kinetic parameters yields 5,069 entries of Ki
values in k_mod. They are assigned entries of the tables enzyme, metabolite and
organism.
So far there are data only for Ki values and none for Ka values.
6. 10,976 kcat values were inserted into the table kcat, each of them with annotations
from the tables enzyme, metabolite and organims. Of these, 5,338 are also linked
to a specified entry from the table reaction.
7. 4994 transcriptional frequencies for genes of the yeast Saccharomyces cerevisiae
were entered into the database. These data were entirely inserted as the data
source had been annotated with ordered locus names.
8. Into the table mrna_half_life 5,257 mRNA half-lives were inserted, one for each
ORF of the the yeast Saccharomyces cerevisiae. The data had originally been
annotated with ordered locus names and could thus be completely inserted into
the database without any loss.
9. 2,088 values for equilibrium constants were filled into the table equilibrium_constant.
The equilibrium constants cover 294 distinct reactions. The original data contain
3,409 equilibrium constants, so in 1,321 cases the original reaction string could not
be mapped to one of reaction names from KEGG REACTION.
10. 9,696 standard free energies of formation for 9441 identifed metabolites are entered
into the database. The original data could be entirely entered into the database
as they were annotated with the appropriate entries of the table metabolite.
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Figure 4.2: The structure of the database resulting from the relationships between the
biological and the parameter entities. Entities and their tables are represented by
boxes with the name inside. The entities that have arrows leaving the box are the
independent entities: metabolite, enzyme, reaction, organism, unit, reference.
The dependent entities are those with arrows pointing onto the respective box:
gene, map_enzyme_reaction, map_gene_enzyme, map_reaction_metabolite,
metabolite_concentration, protein_abundance , mrna_abundance,
km, kcat, k_mod, transcriptional_frequency, equilibrium_constant,
formation_enthalpy.
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model of a metabolic network
In Chap. 4, we described the collection of data in an electronical resource useful for both
model parametrisation and annotation of the data by standard knowledge references that
are electronically accessible. The electronically stored data for parameters are amenable
to computer tools.
We have set up a workflow [23] that automatically generates a kinetic model from
the stoichiometric structure of a metabolic network. We begin either with the structure
of a metabolic network, i.e. metabolites and reactions they participate in, or with a
list of reactions alone from which we then build the stoichiometric structure. This core
metabolic network, so far void of any dynamical information, then is fed into the pipeline.
The pipeline assigns a kinetic formula to each reaction and then parametrises the entire
network. The parametrised kinetics express the fluxes caused by the interactions and
thus lead to a dynamical model.
The workflow, beginning with either a list of reactions or the stoichiometric structure
of a metabolic network, consists of five main steps:
1. set-up of the structure of the metabolic network in the SBML file format [135],
2. assignment of a kinetic law to each reaction in the network,
3. collection of data for the parameters present in the kinetics of the reactions as well
as of data for thermodynamic quantities that confine the kinetic parameters,
4. search of a set of parameters from the collected data accounting for the thermo-
dynamic constraints,
5. output the parametrised model of the metabolic network in the SBML format.
The data for parameters that are stored in the resource generally stem from a variety
of sources, were measured under different conditions and underly inherent as well as
experimental fluctuations. The data at hand for model parametrisation thus are regarded
as cues for model parameters, the true parameters being blurred.
Furthermore, thermodynamical constraints confine numerical values for model pa-
rameters. For this reason we choose a set of a parameters that is thermodynamically
independent.
The set of parameter values that is finally inserted into the model is a function of the
data for the parameters retrieved from the resource. From the extracted data we calcu-
late the thermodynamically independent parameters. From these, in turn, we calculate
the model parameters.
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In order to distinguish between the various parameter types we will in the following
refer to
• data on the one hand as those experimental or computationally derived values of
parameters that stored in the electronical resource, denoted by x∗,
• model parameters as those values that are used for parametrisation of a kinetic
model and
• thermodynamically independent parameters that can be varied freely without break-
ing thermodynamical constraints, denoted by θ.
5.1 Setting up the stoichiometric network
We base the structure of the network models on knowledge contained in KEGG [99].
KEGG is a set of databases that constitute a computer representation of biological
knowledge at different levels, i.e. pathways, reactions, enzymes, compounds and genes.
These levels are interconnected.
The metabolic networks are built from biochemical reactions stored in KEGG. We
start with a set of reactions from the KEGG table REACTION. They are identified by
the respective KEGG REACTION identifier or name. From the corresponding KEGG
REACTION entries we retrieve information on the involved metabolites and enzymes.
Thus, each interaction of the metabolic network is characterised by KEGG identifiers
from the tables REACTION and COMPOUND and by an EC number. Those reactions
that share metabolites are linked and constitute the connections of the network.
In the resulting SBML file encoding the stoichiometric structure of the network, each
component of the network is identified by a MIRIAM-compliant annotations [100]. These
contain Uniform Resource Identfiers (URIs) pointing to the respective external resource
(s. MIRIAM Resources [43]) containing information on the respective network compo-
nent. The data resources in the SBML file encoding the stoichiometry of the metabolic
network are KEGG REACTION, KEGG COMPOUND and Enzyme Nomenclature.
5.2 Assigning kinetics to interactions
In order to turn the model that so far only encodes the stoichiometric topology into a
dynamical model, each reaction is assigned a kinetic expression.
We use the convenience kinetics, a rate law that assumes a random-order enzyme
mechanism and is applicable to reactions with any number of substrates, products and
effectors [103] (s. Eq. (2.24)) for the meaning of the variables and parameters):
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Number of parameters per reaction required for convenience kinetics
Parameter type number required
Km NS +NP
Ki NI
Ka NA
Kcat 2
ET 1
Table 5.1: N
S
: number of substrates, N
P
: number of products, N
I
: number of inhibitors, N
A
:
number of activators of a reaction.
This formula is directly applicable to any network model once its stoichiometric struc-
ture - encoded in the matrix N in Eq. (2.4) - and the regulatory structure - which
effectors act upon an enzyme - are known. Convenience kinetics can thus be used by
computer tools to turn a stoichiometric model into a dynamical one.
The number of kinetic parameters that is needed for modelling a network with conve-
nience kinetics in Eq. (5.1) is: one Km value for each substrate or product, one Ka value
for each activator of the enzyme, one Ki value for each inhibitor and two turnover rates
of the enzyme k±cat, one for either reaction direction, and the total enzyme concentration
ET . The total number of parameters needed per reaction is thus NS +NP +NA +NI +3
as indicated in Tbl. 5.1 with NS , NP , NI , and NA denoting the number of substrates,
products, activators and inhibitors of the reaction, respectively.
5.3 Retrieving the appropriate data for the parameters
The database containing data for parameters of kinetic models of metabolism which
was presented in the Chap. 4 is used for model parametrisation. So far the model,
encoded in SBML, is a mere stoichiometric structure of biochemical reaction containing
no dynamical information about the enzyme mechanisms. The stoichiometric structure
of the model is annotated with identifiers of standard references denoting the components
of the metabolic network and the biochemical reactions.
This information about the components and biochemical interactions of the network is
used to retrieve relevant parameters from the database. The metabolic network is likely
to be modelled for a specific organism. For this organism the following information is
searched in the resource.
1. KEGG COMPOUND identifiers are used to find concentrations of metabolites
from the table metabolite_concentration.
2. EC numbers are used for collecting the respective protein abundances. As protein
abundances are annotated with the appropriate ORF name of the gene that encodes
it, further information is needed to link EC numbers and ORFs. This is achieved
with information from KEGG ENZYME. Knowing which enzyme is encoded by
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Properties of distributions of data in database
quantity mean std. dev. 5%-quant. median 95%-quant.
metabolite concentration (mM) 1.419 4.496 0.003 0.123 5.15
protein abundance 10605 48174 279 2939 33502
mRNA abundance 3.33 13.85 0.1 0.76 10.0
Km (mM) 15.50 392.10 0.001 0.14 20.005
Ki (mM) 11.9 173.0 3 · 10−6 0.016 13.7
kcat (1/s) 1898 26757 0.008 6 1100
transcriptional freq. (1/hr) 7.4 19.6 0.3 2 28.9
mRNA half-life (min) 18.8 9.80 10 16 36
equilibrium constant 123.5 2303.4 10−6 0.119 160.6
Gibbs energy of form. (kJ/mol) -435.146 642.999 -1522.6 -331.0 324.3
Table 5.2: The parameter types collected in the database. Shown are properties of their distri-
butions. All data show strong discrepancies between mean and median.
which gene, we can search for a protein abundance value for a given EC number
for the table protein_abundance.
3. As kinetic parameters concern interactions more than one piece of information
is required for their retrieval from the database. Km values are looked for with a
given EC number, the KEGG COMPOUND identifier of the substrate. If possible,
the KEGG REACTION identifier will also be taken into account.
4. Thermodynamic data for the biochemical reactions of the metabolic networks are
searched by KEGG COMPOUND identifiers in the case of Gibbs free energies
of formation of metabolites and by KEGG REACTION identifiers in the case of
apparent equilibrium constants.
5.4 Uncertain parameters
The collected experimental data x∗ cannot be directly written into the kinetics of the
reactions of the metabolic network. The found data x∗ are uncertain and we calculate
model parameters x from them by first finding a set of thermodynamically independent
parameters θ. The method we adopt is represented by the scheme
x∗ −→ θ −→ x .
In the calculation of the model parameters x from the data x∗ we will switch to the
logarithms of the parameters and data. There are three reasons for this. Firstly, this
makes the mapping between θ and x linear (s. below).
Secondly, as the quality and quantity of data is insufficient for consistent data for the
model parameters we will construct probability density functions for the parameters. The
probability distributions for the logarithmic parameters are approximated by Gaussian
distributions, i.e. the actual parameters are log-normal variables. When we speak about
logarithmic parameters we will stick to the names x, x∗ and θ.
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Properties of the distributions of the logarithmic parameters
quantity mean std. dev. 5% –quantile median 95% –quantile
metabolite concentration -0.92 1.07 -2.59 -0.91 0.71
protein abundance 3.45 0.62 2.45 3.47 4.53
mRNA abundance -0.08 0.61 -1 -0.12 1
Km predicted -0.43 0.61 -1.35 -0.42 0.47
Km from literature -0.86 1.34 -3.01 -0.85 1.3
Ki -1.95 2.06 -5.51 -1.8 1.14
kcat 0.66 1.59 -2.1 0.78 3.04
transcriptional frequency 0.36 0.6 -0.52 0.3 1.46
mRNA half-life 1.24 0.17 1 1.2 1.56
equilibrium constant -1.4 2.42 -5.99 -0.92 2.21
Gibbs energy of formation 2.14 0.54 1.13 2.21 2.89
Table 5.3: Shown are the properties of the distributions of the logarithmic parameters from the
database. The means and medians are all close or very close except for the distribu-
tion of the equilibrium constants. For metabolite concentration, protein abundance
and the Km values the 5%-quantile and the 95%-quantile are symmetrically located
around the median.
Thirdly, several data entries for a single parameters can be found in the database. And
these can be considerably different in their order of magnitude. Averaging of logarithmic
values of data copes better with large differences in the order of magnitude.
Uncertainties in the data x∗ are manifest in different ways.
(i) Experimental data are noisy because of measurement errors. Sources of noise
are biological variability, measurement errors and in vitro measurements in non-
appropriate conditions.
(ii) Many parameters will not be available and therefore remain undetermined.
We nevertheless try to assign values to Km values when data do not exist. When
the database does not contain a Km value present in a network model we make
a guess based on knowledge about Km values for the same enzyme in different
organisms and for different enzymes in the same organism. We guess the missing
Km value based on a statistical linear model [22].
The idea behind is that there are different factors that explain aKm value. The first
of the three factors is the substrate contribution µ determined by the substrate’s
chemical properties that determine its binding to enzymes. Second, we presume
conservation across organism of properties in the enzyme-substrate binding leading
to factor α determined by the enzyme. The third factor β is the contribution from
the organism assuming that enzyme adapts to typical substrate concentrations in
the cell as it is the ration of the substrate concentration to the Km value that
determines the saturation of the enzyme. The logarithm of the Km value is the
ln(Km) = µ + α + β. This calculated guess of a missing Km value is then joined
to the set of collected data x∗.
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(iii) We may find different different measured values, possibly also different orders of
magnitude for the same parameter. In case more than one data for a specific
parameter are found all data are taken into account and their contribution in the
calculation of the set of model parameters x is weighted.
(iv) Thermodynamics imposes constraints on possible kinetic parameter values [103]
as strict adherence to Haldane relationships must take place (s. Sect. 2.5), be it
by measurement or estimation. The thermodynamical constraints only allow for
certain combinations of parameter values. In fact, we choose a set of independent
parameters θ and calculate the complete set of parameters x from it.
For a network modelled with convenience kinetics the following Haldane relation-
ship confines the parameter values [103]:
Keq =
∏
P
(cP )
n
P∏
S
(cS )
n
S
=
k+cat
∏
P
(KmP )nP
k−cat
∏
s
(KmS)nS
. (5.2)
In order to ensure thermodynamic consistency of the parameter set, we regard
the turnover rates k±cat as dependent on each other. We choose the geometric
mean of them to be independent and call it the velocity constant kV =
√
k+catk
−
cat.
With independent parameters Keq, KmS , KmP and kV , both k+cat and k−cat can be
calculated from Eq. (5.2) (for details s. [103]).
Going further and we express the equilibrium constant Keq through Gibbs energies
of formation of the metabolites involved in the reaction according to Eqs. (2.29) and
(2.30). This is useful when data of Gibbs free energies of formation for the reacting
metabolites are available. With Eq. (2.30) the Haldane relationship Eq. (5.2) then
becomes
e−∆G
0/RT =
k+cat
∏
P
(KmP )nP
k−cat
∏
S
(KmS)nS
with (s. Eq. (2.29))
∆G0 =
∑
P
nPµ
0
P
−
∑
S
nSµ
0
S
.
If we take the logarithm of the Haldane relationship (5.2) we get a linear depen-
dency of the logarithmic parameters among each other. The same holds for the
general Haldane Eq. (2.34) and for Eq. (2.29). We thus establish a linear relation-
ship
x(θ) = Rxθ θ (5.3)
between the independent parameters θ and the dependent parameters x [103],
where the matrix Rxθ is completely determinded by the network topology.
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Figure 5.1: Prior distributions of logarithms of different data types used in the Bayesian param-
eter estimation approach.
We now relate the logarithms of the parameter data x∗ retrieved from the electronical
resource to the logarithms of the true parameters values x by
x∗ = x+  (5.4)
where  is the uncertainty concerning the data.
Given collected parameter data x∗ we estimate the independent parameters θˆ from
Eq. (5.3) by error minimisation. This corresponds to a maximum likelihood estimation
with the likelihood function
L(θ) = p(x = x∗|θ)
and the estimated independent parameters
θˆ = max
θ
L(θ) .
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We then plug the estimates back into Eq. (5.3) to yield the full set of (thermodynamically
dependent) parameters x.
In order to account for already existent knowledge about the independent parameters θ
we further employ Bayesian inference to determine the posterior probability distribution
of θ given x∗:
p(θ|x = x∗) ∝ p(θ) L(θ) . (5.5)
The prior distributions p(θ) for the independent parameters θ representing general
knowledge about the parameters we obtain from the information in the database. These
prior distributions p(θ) we derive from a statistics over all collected data for each param-
eter type. The properties of the distributions of the data in the database are indicated in
Tbl. 5.2, for the logarithmic data in Tbl. 5.3. The distributions of some of the logarithmic
parameters are also shown in Fig. 5.1.
For instance, a log-normal distribution fitted to the distribution of Km values in the
database Brenda [134] is used as a prior for each Km value in the network (in Fig. 5.1
the Km designated as from literature and databases).
With the posterior distribution from Eq. (5.5) different parameter set x can be calcu-
lated from different sets of thermodynamically independent parameters θ. The x are then
inserted into the model and its dynamical properties can be assessed by simulation. By
random sampling from the posterior distribution p(θ|x = x∗) we can find distributions
of the behaviour of the model [21, 102].
5.5 Kinetic model
Once the entities of the metabolic network, i.e. reactions, metabolites and enzymes,
are assigned their parameters, the result is written to an output file in SBML format.
The annotations in the SMBL file accord with the MIRIAM standard [100, 43]. The
dynamical model can then be simulated with any tool that is able to read SBML files.
5.6 Application to Sulfur-Methionine-Pathway in
Saccharomyces cerevisiae
As a test case, we applied the described automatic model generation to the sulphur
assimilation and the glutathione biosynthesis pathways in the yeast Saccharomyces cere-
visiae. These pathways play an important role in the buffering of arsenic in order to
avoid toxic effects: the cell increases the uptake of sulphur, leading to a raised glu-
tathione level. Glutathione, having a high reduction potential, forms a complex with
arsenic and the complex then is disposed in the vacuoles. The expression of the enzymes
involved in these pathways is enhanced upon exposure to arsenic [137].
From a manually sketched metabolic network of the sulphur assimilation and the glu-
tathione biosynthesis pathways, an enhanced version of the model in [137], we looked up
the KEGG reaction identifiers. With these identifiers, information about the reactants
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Statistics of data retrieved for model.
number of data found for
quantity S. cerev. Glutathione synthesis
protein abundance 10141 13 of 15 enzymes
metabolite conc. 30 7 of 36 metabolites
Km 2475 30 of 73 enzyme-metabolite pairs
k±cat 144 0 of 16 reversible reactions
equilibrium constant - 2 of 16 reactions
Gibbs energy of form. - 20 of 36 metabolites
Table 5.4: The number of data of different parameter types in the database, how many of them
apply to Saccharomyces cerevisiae and how many have been extracted for the model
(not only kinetic parameters).
and enzymes is fetched from the KEGG database. The result is the metabolic network
shown in Fig. 5.2. We have so far not included any inhibitions or activations.
In the data retrieval step we could find 130 entries some of them refer to the same
parameter of the model and are averaged. Among the data are 34 protein abundances, 7
metabolite concentrations, 30 Km values, 26 Ki values, 2 equilibrium constants and 53
Gibbs free energies of formation. After averaging data belonging to the same component
or interaction of the network we are left with 48 parameters: 13 protein abundances,
7 metabolite concentrations, 29 Km values, 2 equilibrium constants and 20 Gibbs free
energies of formation. No kcat value could be found for this network (s. Tbl. 5.4).
Thus, most of the Km values are missing and a large part of the metabolites no Gibbs
free energies of formation are available. This are not even enough data to completely
determine the model thermodynamically. Or stated otherwise, with the fetched data x∗
not even all the thermodynamically independent parameters θ are assigned numerical
values.
But all therodynamically independent parameters θ need to be ascribed values in order
to calculate a complete set of model parameters x. As long as no other data are available
we will set the parameter type to the mean value of the respective prior. This way we
get a completely parametrised model.
The prior distributions of the logarithms of the parameters are shown in Fig. 5.1. In
some cases they can be well described by a normal distributions (i.e. the parameter itself
is log-normal distributed). Especially where the number of collected data (s. Tbl. 5.2) is
large the normal distribution is a good description of the respective actual distribution.
This is the case for the Km, Ki, kcat values and the Gibbs free energies of formation.
The kinetic parameters of the model are determined by 144 kinetic and thermodynamic
values. Those parameters for which no data can be extracted from the database are
mainly determined by the mean values of their prior distributions (s. Tbl. 5.3) and then
undergo the thermodynamical adjustment and Bayesian procedure.
In Figs. 5.3 and 5.4 we show, for an example, the Km values of the model. In the top
figure we display the Km values extracted from the database (missing data are indicated
by grey diamonds with black borders) and their numerical values. In the bottom figure we
display the model parameters after the replacement of missing values and the adjustment
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to thermodynamical constraints in the course of the Bayesian procedure. High numerical
values tend to stay high, missing ones are replaced by “average” numerical values.
When simulated with initial concentration values of the metabolites in the range of
0.1mM to 10mM, and holding the concentrations of the coenzymes constant, the model
yields concentrations in the range of 1µM to 1mM. The fluxes obtain values in the range
of 1nM/s to 1µM/s.
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Figure 5.2: An automatically generated metabolic network set up starting with the KEGG
REACTION identifiers R00529, R00509, R02021, R00858, R01287, R00192, R00380,
R00177, R00946, R01290, R01001, R03217, R00894, R00497, R00494, R00899.
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Figure 5.3: Michaelis-Menten constants in the sulphur-glutathione model. In this figure the
Km values for the model of sulphur metabolism retrieved from the database are
displayed. The colour bar to the left indicates the logarithm of the respective Km
value measured in mM. The Km values that are not assigned a value after the
database search are shown in grey.
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Figure 5.4: In this figure the Km values are displayed after the model has been fully
parametrised in a thermodynamically consistent manner. Those Km parameters
for which no data are available, indicated by grey diamonds in Fig. 5.3, are set to
an average value. Km parameters for which data were retrieved from the database,
indicated by colored diamonds in Fig. 5.3, tend to keep their values. The colour bar
to the left indicates the logarithm of the respective Km value measured in mM.
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6 Discussion
Systems biology seeks to gain an understanding of biological networks by modelling them
dynamically. Ultimately this means revealing the proteins and their interaction networks
in the cell.
Interactions of proteins are at the basis of any process in biology. They entail changes
in protein’s abundances in space and time. They determine a protein’s function.
The identification of protein interactions in the cell is a formidable task. A wealth of
techniques for discovering interaction of proteins with proteins or with other molecules
like nucleic acids exists. A recent area of research, called chemical genomics, screens
small molecules for the binding and modulating properties with respect to proteins.
But system biology requires knowledge not only about which network components
interact. Systems biology needs dynamical knowledge about those interactions. In order
to model interaction networks parameters need to be known that determine at which
rates the interactions occur.
In Chap. 2 we give a brief introduction into the modelling of metabolic networks. De-
terministic modelling of the dynamics of metabolism is based on rate equations. These
require parameters that have to be measured. Time scale separation can save computa-
tional cost by concentrating on the processes that act on a particular time scale. This was
shown with the example of Michaelis-Menten kinetics. Furthermore convenience kinetics
were introduced that represent a random-order enzyme kinetics suited for automatically
assigning kinetics to a reaction. We also point to the importance of thermodynamic
consistency of kinetic parameters in a metabolic network.
If the vision of an in silico cell is to come true the interactions of, in principle, every
single protein need to be quantitatively characterised. But the fact is, that to date not
even models of subsystems can be fully and consistently parametrised. Data do either
not exist or quality of data is poor. Indeed, discrepancies between measured fluxes
and metabolite concentrations, on the one hand, and calculated ones from a model
with measured kinetic parameters have been reported [136]. Parameters are either not
known or of doubtful quality because in vitro enzyme assays often do not reflect in
vivo conditions. Modellers mostly have to resort to parameter estimation. Altogether,
knowledge about kinetic parameters is uncertain.
In Chap. 3 we examined the question of how uncertainties in the parameters of a
kinetic model can entail different dynamical properties of a system. Specifically, we
chose a system called the repressilator [45] which is a genetic network of three genes
inhibiting one another such that a cycle forms.
This network either tends to a steady state or exhibits persistent ocscillations depend-
ing on the shape of the signal-response curve describing the interaction between the
genes. With steeper signal-response sustained oscillations get more likely. This depends
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on a single parameter, namely the Hill coefficient. This kind of assessment of possi-
ble dynamical properties of a dynamical network is helpful in determining where in the
network further experimental investigation could be critical to increase the knowledge
about a system.
With the advent of systems biology the need for electronically stored information is
growing in order to exchange the rapidly increasing amounts of data and information.
Electronical resources for different kinds of knowledge have been constructed. Those like
KEGG or RefSeq represent biological knowledge. Others contain experimental data like
ArrayExpress or GEO. BRENDA is a resource for information on enzyme kinetics.
For systems biology it will be important to link these different knowledgebases, to
join for instance kinetic knowledge in BRENDA with biological knowledge in KEGG.
So far, BRENDA categorises its knowledge according to the EC nomenclature and uses
systematic organism names. But, for instance, substrate names are usually taken from
the literature sources.
In Chap. 4 we present an effort to collect data about biological networks and to
store them in a repository that makes them not only human readable but accessible to
machines and automated handling. We have collected various data types.
Data for abundances of networks components like proteins or mRNAs are relatively
easy to manage: each data value is annotated with the appropriate network component
and possibly further explanatory information like the organism and experimental con-
ditions. But data regarding interactions of network components are more involved to
annotate because it takes at least the two interacting components to identify.
We undertook the effort of connecting kinetic data stored in BRENDA with data
from KEGG. We compared information used to annotate data in BRENDA with the
respective knowledge stored in KEGG by string comparison. The main difficulty was to
coalesce substrate names in BRENDA with metabolites in KEGG. The reason is the lack
of any adopted standard nomenclature for small molecules. The difference of a prefix in
the names can already render impossible to join what a human readily joins. A lot of
BRENDA data were lost because the substrate names could not be mapped.
In Chap. 5 we introduce a pipeline to automatically set up dynamical models of
metabolic networks. This pipeline uses the database containing abundance, interaction
and thermodynamic data presented in Chap. 4. It constructs a stoichiometric network
and searches data for kinetic parameters, component abundances and thermodynamic
quantities after every reaction has been assigned a kinetics according to the convenience
kinetics scheme.
Convenience kinetics are readily assigned in an automated fashion to any biochemical
reaction including effectors. It represent a random-order mechanism and remedies the
lack of knowledge about enzyme mechanisms or the electronical inaccessibility of this
knowledge.
The data assigned to the kinetics are scarce, mostly of poor quality and seldom ther-
modynamically consistent. We thus take the data, fill the gaps of missing data and
infer a fully parametrised, thermodynamically consistent kinetic model in a Bayesian
approach.
In order to achieve a fully parametrised kinetic model a minimum set of independent
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parameters needs to be assigned values. But the data stored in the database are not
numerous enough to do the job. In order compensate for these gaps and parametrise the
whole network we have a model for predicting missing Km values based on present data.
For other data types the information in the prior distribution has to suffice as long as not
more data are available or, for instance, BRENDA data are not better linked to resources
like KEGG. Setting up a standard nomenclature for these so-called small molecules is
the necessary step to resolve this problem. ChEBI, for instance, is a dictionary tackling
this problem.
The constructed kinetic models are models in progress. Whenever more knowledge
is available it can be included in the parametrisation. The models will thus hopefully
become more realistic in the course iterative improvements. For instance, time course
data of metabolites could be incorporated. They would represent the data and the
distributions from the first step the prior information. One day we will hopefully have
access to sufficient data of quality to model biological networks realistically.
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Derivation of Michaelis-Menten kinetics by
time scale separation
A classical example for time scale separation is the minimal metabolic networkS + E k+1⇀↽
k−1
ES
 k2→ P (.1)
consisting of one irreversible enzyme catalysed reaction turning over species S into
species P where E denotes the enzyme and ES the complex of enzyme and substrate.
The simplification in the dynamic description after time scale separation leads to
Michaelis-Menten-kinetics. The fast process in this network is the binding of the sub-
strate S to the enzyme E
S + E
k+1
⇀↽
k−1
ES , (.2)
the process of interest is the production rate of product P
ES
k2
→ P , (.3)
the slow process is the change of total enzyme concentration ET = E+ES because gene
expression and protein degradation act on longer time scales. This leads to
dES
dt
= k+1 · S · E − (k−1 + k2) · ES (.4)
dP
dt
= k2 · ES (.5)
dET
dt
= 0 . (.6)
We solve the fast variable condition from Eq.(.4)
0 = k+1 · S · E − (k−1 + k2) · ES
for ES in order to insert it into Eq.(.5), thereby using the fact that the slow variable
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remains constant (Eq.(.6)) by substitution of E = ET − ES. We find
ES = ET
S
k−1+k2
k+1
+ S
(.7)
= ET
S
Km + S
(.8)
where the Michaelis-Menten constant is defined as Km = (k−1 + k2)/k+1. This leads to
following rate equation for the product P :
dP
dt
= k2ET
S
Km + S
(.9)
and the reaction scheme (.1) can be replaced by the following scheme
S
(ET ,Km,k2)−→ P . (.10)
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